CC02480
     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -4.8240    1.5365    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -4.1096    1.1240    0.0000 N   0  0  0  0  0  0  0  0  0  2  0  0
   -3.3951    1.5365    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -2.6806    1.1240    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -1.9662    1.5365    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -1.2517    1.1240    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -0.4671    0.8691    0.0000 O   0  0  0  0  0  0  0  0  0  7  0  0
   -0.4671    0.0441    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -1.2517   -0.2109    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -1.5872   -0.9645    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -2.4077   -1.0508    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -2.8927   -0.3833    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -2.5571    0.3703    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -1.7366    0.4566    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -2.7433   -1.8044    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -3.0788   -2.5581    0.0000 N   0  0  0  0  0  0  0  0  0 16  0  0
   -0.9161    1.8777    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -1.4011    2.5451    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -1.0655    3.2988    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -0.2450    3.3850    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    0.0905    4.1387    0.0000 F   0  0  0  0  0  0  0  0  0 21  0  0
    0.2399    2.7176    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -0.0957    1.9639    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  6 14  1  0
  9 14  1  0
 11 15  1  0
 15 16  3  0
  6 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 17 23  1  0
M  END
>  <Name>  (1) 
Desmethylcitalopram

>  <InChIKey>  (1) 
PTJADDMMFYXMMG-UHFFFAOYSA-N

>  <PubChem_CID>  (1) 
162180

>  <CYP1A2>  (1) 


>  <CYP2A6>  (1) 


>  <CYP2B6>  (1) 


>  <CYP2C8>  (1) 


>  <CYP2C9>  (1) 


>  <CYP2C19>  (1) 


>  <CYP2D6>  (1) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R1>
<3,H;Oxidation;R1>

>  <CYP2E1>  (1) 


>  <CYP3A4>  (1) 


>  <References>  (1) 
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (1) 


$$$$
CC02481
     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.7145    2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    1.4289    2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    2.1434    2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    2.1434    1.2375    0.0000 N   0  0  0  0  0  0  0  0  0  4  0  0
    2.8579    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    3.5724    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    4.2868    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    4.2868   -0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    3.5724   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    2.8579    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    2.1434   -0.4125    0.0000 S   0  0  0  0  0  0  0  0  0 11  0  0
    1.4289    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    0.7145   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    0.0000    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    0.7145    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    1.4289    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    1.4289    3.3000    0.0000 N   0  0  0  0  0  0  0  0  0 18  0  0
    0.7145    3.7125    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    2.1434    3.7125    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  5 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  4 17  1  0
 12 17  1  0
  2 18  1  0
 18 19  1  0
 18 20  1  0
M  END
>  <Name>  (2) 
Promethazine

>  <InChIKey>  (2) 
PWWVAXIEGOYWEE-UHFFFAOYSA-N

>  <PubChem_CID>  (2) 
4927

>  <CYP1A2>  (2) 


>  <CYP2A6>  (2) 


>  <CYP2B6>  (2) 


>  <CYP2C8>  (2) 


>  <CYP2C9>  (2) 


>  <CYP2C19>  (2) 


>  <CYP2D6>  (2) 
<19,18;Cleavage;R1>
<19,H;Oxidation;R1>
<20,18;Cleavage;R2>
<20,H;Oxidation;R2>
<11,S;S-Oxidation;R3>

>  <CYP2E1>  (2) 


>  <CYP3A4>  (2) 


>  <References>  (2) 
Rudik AV, Dmitriev AV, Lagunin AA, Filimonov DA, Poroikov VV: Prediction of reacting atoms for the major biotransformation reactions of organic xenobiotics. J Cheminform. 2016 Nov 28;8:68. doi: 10.1186/s13321-016-0183-x. eCollection 2016. (PMID: 27994650)
Nakamura K, Yokoi T, Inoue K, Shimada N, Ohashi N, Kume T, Kamataki T: CYP2D6 is the principal cytochrome P450 responsible for metabolism of the histamine H1 antagonist promethazine in human liver microsomes. Pharmacogenetics. 1996 Oct;6(5):449-57. (PMID: 8946477)

>  <Comments>  (2) 


$$$$
CC02482
     RDKit          2D

 20 20  0  0  0  0  0  0  0  0999 V2000
    2.1434   -2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    2.1434   -2.8875    0.0000 O   0  0  0  0  0  0  0  0  0  2  0  0
    2.8579   -3.3000    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    2.8579   -4.1250    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    2.1434   -4.5375    0.0000 O   0  0  0  0  0  0  0  0  0  5  0  0
    3.5724   -4.5375    0.0000 N   0  0  0  0  0  0  0  0  0  6  0  0
    4.2868   -4.1250    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    5.0013   -4.5375    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    4.2868   -3.3000    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    3.5724   -2.8875    0.0000 O   0  0  0  0  0  0  0  0  0 10  0  0
    5.0013   -2.8875    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
    5.7158   -3.3000    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    3.5724   -5.3625    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    4.2868   -5.7750    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    5.0013   -5.3625    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    4.2868   -6.6000    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    3.5724   -7.0125    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    2.8579   -6.6000    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    2.8579   -5.7750    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    2.1434   -5.3625    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
  6 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 13 19  1  0
 19 20  1  0
M  END
>  <Name>  (3) 
Metalaxyl

>  <InChIKey>  (3) 
ZQEIXNIJLIKNTD-UHFFFAOYSA-N

>  <PubChem_CID>  (3) 
42586

>  <CYP1A2>  (3) 


>  <CYP2A6>  (3) 


>  <CYP2B6>  (3) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2C8>  (3) 


>  <CYP2C9>  (3) 


>  <CYP2C19>  (3) 


>  <CYP2D6>  (3) 


>  <CYP2E1>  (3) 


>  <CYP3A4>  (3) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <References>  (3) 
Abass K, Reponen P, Jalonen J, Pelkonen O: In vitro metabolism and interactions of the fungicide metalaxyl in human liver preparations. Environ Toxicol Pharmacol. 2007 Jan;23(1):39-47. doi: 10.1016/j.etap.2006.06.004. Epub 2006 Jun 17. (PMID: 21783735)

>  <Comments>  (3) 


$$$$
CC02484
     RDKit          2D

 24 28  0  0  1  0  0  0  0  0999 V2000
   -1.3893   -2.6506    0.0000 O   0  0  0  0  0  0  0  0  0  1  0  0
   -0.6527   -3.0222    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    0.0374   -2.5701    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
   -0.0091   -1.7464    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    0.1897   -0.7874    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    1.1588   -1.0858    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    2.2236   -0.8732    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    2.1917   -0.2923    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    1.3402   -0.0421    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    0.7546   -0.6916    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -0.2474   -1.0199    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    1.2806   -1.6558    0.0000 N   0  0  0  0  0  0  0  0  0 12  0  0
    2.1718   -1.9142    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    2.7185   -1.1656    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    3.5427   -1.2018    0.0000 O   0  0  0  0  0  0  0  0  0 15  0  0
   -0.6062   -3.8459    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    0.0875   -4.2924    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -0.1229   -5.0901    0.0000 N   0  0  0  0  0  0  0  0  0 18  0  0
   -0.9466   -5.1366    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -1.4632   -5.7798    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -2.2785   -5.6540    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -2.5773   -4.8850    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -2.0606   -4.2418    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -1.2453   -4.3676    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
  1  2  2  0
  2  3  1  0
  4  3  1  1
  4  5  1  0
  6  5  1  1
  6  7  1  0
  8  7  1  6
  8  9  1  0
  9 10  1  0
 10 11  1  6
  4 11  1  0
 10 12  1  0
  6 12  1  0
 12 13  1  0
 13 14  1  0
  8 14  1  0
 14 15  2  0
  2 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 16 24  1  0
 19 24  1  0
M  END
>  <Name>  (4) 
Dolasetron

>  <InChIKey>  (4) 
UKTAZPQNNNJVKR-KPWCQOOUSA-N

>  <PubChem_CID>  (4) 


>  <CYP1A2>  (4) 


>  <CYP2A6>  (4) 


>  <CYP2B6>  (4) 


>  <CYP2C8>  (4) 


>  <CYP2C9>  (4) 


>  <CYP2C19>  (4) 


>  <CYP2D6>  (4) 


>  <CYP2E1>  (4) 


>  <CYP3A4>  (4) 


>  <References>  (4) 
Zhou SF: Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin Pharmacokinet. 2009;48(12):761-804. doi: 10.2165/11318070-000000000-00000. (PMID: 19902987)
Zhou SF: Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. Clin Pharmacokinet. 2009;48(11):689-723. doi: 10.2165/11318030-000000000-00000. (PMID: 19817501)

>  <Comments>  (4) 


$$$$
CC02485
     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
   -7.1447   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -7.1447   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -6.4302   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -6.4302   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -5.7158   -0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -5.7158    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -5.0013    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -4.2868    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -3.5724    1.2375    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
   -2.8579    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -2.1434    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -1.4289    0.8250    0.0000 N   0  0  0  0  0  0  0  0  0 12  0  0
   -0.7145    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -1.4289   -0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -4.2868   -0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -5.0013   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -7.1447   -0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -7.8592   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -8.5737   -0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -8.5737    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -7.8592    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -7.8592    2.0625    0.0000 O   0  0  0  0  0  0  0  0  0 22  0  0
   -7.1447    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -5.7158   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -5.0013   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
   -4.2868   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -4.2868   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
   -5.0013   -2.8875    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
   -5.7158   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
  8 15  1  0
 15 16  2  0
  5 16  1  0
  4 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
 17 23  1  0
  3 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 24 29  1  0
M  END
>  <Name>  (5) 
Droloxifene

>  <InChIKey>  (5) 
ZQZFYGIXNQKOAV-OCEACIFDSA-N

>  <PubChem_CID>  (5) 
3033767

>  <CYP1A2>  (5) 


>  <CYP2A6>  (5) 


>  <CYP2B6>  (5) 


>  <CYP2C8>  (5) 


>  <CYP2C9>  (5) 


>  <CYP2C19>  (5) 


>  <CYP2D6>  (5) 
<14,12;Cleavage;R1>
<14,H;Oxidation;R1>
<13,12;Cleavage;R2>
<13,H;Oxidation;R2>

>  <CYP2E1>  (5) 


>  <CYP3A4>  (5) 
<14,12;Cleavage;R1>
<14,H;Oxidation;R1>
<13,12;Cleavage;R2>
<13,H;Oxidation;R2>

>  <References>  (5) 
Zhou SF: Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. Clin Pharmacokinet. 2009;48(11):689-723. doi: 10.2165/11318030-000000000-00000. (PMID: 19817501)
Zhou SF: Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin Pharmacokinet. 2009;48(12):761-804. doi: 10.2165/11318070-000000000-00000. (PMID: 19902987)

>  <Comments>  (5) 


$$$$
CC02486
     RDKit          2D

  3  2  0  0  0  0  0  0  0  0999 V2000
    1.2375   -0.7145    0.0000 Cl  0  0  0  0  0  0  0  0  0  1  0  0
    1.9520   -1.1270    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    2.6664   -0.7145    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
  1  2  1  0
  2  3  2  0
M  END
>  <Name>  (6) 
Vinyl chloride

>  <InChIKey>  (6) 
BZHJMEDXRYGGRV-UHFFFAOYSA-N

>  <PubChem_CID>  (6) 
6338

>  <CYP1A2>  (6) 


>  <CYP2A6>  (6) 


>  <CYP2B6>  (6) 


>  <CYP2C8>  (6) 


>  <CYP2C9>  (6) 


>  <CYP2C19>  (6) 


>  <CYP2D6>  (6) 


>  <CYP2E1>  (6) 
<2,3;EpOxidation;R1>

>  <CYP3A4>  (6) 


>  <References>  (6) 
Brown CM, Reisfeld B, Mayeno AN: Cytochromes P450: a structure-based summary of biotransformations using representative substrates. Drug Metab Rev. 2008;40(1):1-100. doi: 10.1080/03602530802309742. (PMID: 18259985)

>  <Comments>  (6) 


$$$$
CC02487
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
    0.9458    3.6320    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    1.6603    4.0445    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    1.6603    4.8695    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    2.3747    5.2820    0.0000 N   0  0  0  0  0  0  0  0  0  4  0  0
    3.0892    4.8695    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    3.0892    4.0445    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    3.8037    3.6320    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    3.8037    2.8070    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
    4.5181    2.3945    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    4.5181    1.5695    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    3.8037    1.1570    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    3.0892    1.5695    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    3.0892    2.3945    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    3.8037    0.3320    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    4.5470   -0.0260    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    5.1517    0.5352    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    5.9401    0.2920    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    6.1237   -0.5123    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    6.9120   -0.7555    0.0000 Cl  0  0  0  0  0  0  0  0  0 19  0  0
    5.5189   -1.0735    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    4.7305   -0.8303    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    4.2162   -1.4753    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    3.3912   -1.4753    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    2.8768   -0.8303    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
    2.0884   -1.0735    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    1.4837   -0.5123    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
    1.6673    0.2920    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
    2.4556    0.5352    0.0000 N   0  0  0  0  0  0  0  0  0 28  0  0
    3.0604   -0.0260    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
    2.3747    3.6320    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  8 13  1  0
 11 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 15 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 14 29  1  0
 24 29  1  0
  6 30  2  0
  2 30  1  0
M  END
>  <Name>  (7) 
Rupatadine

>  <InChIKey>  (7) 
WUZYKBABMWJHDL-UHFFFAOYSA-N

>  <PubChem_CID>  (7) 
133017

>  <CYP1A2>  (7) 


>  <CYP2A6>  (7) 


>  <CYP2B6>  (7) 


>  <CYP2C8>  (7) 


>  <CYP2C9>  (7) 


>  <CYP2C19>  (7) 


>  <CYP2D6>  (7) 


>  <CYP2E1>  (7) 


>  <CYP3A4>  (7) 
<7,8;Cleavage;R1>
<7,H;Oxidation;R1>

>  <References>  (7) 
Taubel J, Ferber G, Fernandes S, Lorch U, Santamaria E, Izquierdo I: Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial. PLoS One. 2016 Sep 15;11(9):e0163020. doi: 10.1371/journal.pone.0163020. eCollection 2016. (PMID: 27632557)
Pharmacorama (2010) Rupatadine, Wystamm, H1 Antihistamine [French] [https://www.pharmacorama.com/2010/01/rupatadine-wystamm-antihistaminique-h1/]

>  <Comments>  (7) 


$$$$
CC02488
     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
    2.8579    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    2.1434    0.4125    0.0000 O   0  0  0  0  0  0  0  0  0  2  0  0
    2.1434   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    1.4289   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    1.4289   -1.6500    0.0000 O   0  0  0  0  0  0  0  0  0  5  0  0
    0.7145   -2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    0.7145   -2.8875    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    1.4289   -3.3000    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
    2.1434   -2.8875    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    2.8579   -3.3000    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    3.5724   -2.8875    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
    4.2868   -3.3000    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    0.0000   -3.3000    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -0.7145   -2.8875    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -1.4289   -3.3000    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -1.4289   -4.1250    0.0000 N   0  0  0  0  0  0  0  0  0 16  0  0
   -2.1434   -4.5375    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -2.1434   -5.3625    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -2.8579   -5.7750    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -3.5724   -5.3625    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -3.5724   -4.5375    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -2.8579   -4.1250    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -2.8579   -6.6000    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -2.8579   -7.4250    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -2.1434   -2.8875    0.0000 N   0  0  0  0  0  0  0  0  0 25  0  0
   -2.1434   -2.0625    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -1.4289   -1.6500    0.0000 N   0  0  0  0  0  0  0  0  0 27  0  0
   -0.7145   -2.0625    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
    0.0000   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  7 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 17 22  1  0
 19 23  1  0
 23 24  3  0
 15 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 14 28  1  0
 28 29  2  0
  6 29  1  0
M  END
>  <Name>  (8) 
Erlotinib

>  <InChIKey>  (8) 
AAKJLRGGTJKAMG-UHFFFAOYSA-N

>  <PubChem_CID>  (8) 
176870

>  <CYP1A2>  (8) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2A6>  (8) 


>  <CYP2B6>  (8) 


>  <CYP2C8>  (8) 


>  <CYP2C9>  (8) 


>  <CYP2C19>  (8) 


>  <CYP2D6>  (8) 


>  <CYP2E1>  (8) 


>  <CYP3A4>  (8) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <References>  (8) 
Wang B, Zhou SF: Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr Med Chem. 2009;16(31):4066-218. (PMID: 19754423)

>  <Comments>  (8) 


$$$$
CC02489
     RDKit          2D

 19 20  0  0  0  0  0  0  0  0999 V2000
    1.4289   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    1.4289   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    2.0964   -2.9599    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    1.8414   -3.7445    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    1.0164   -3.7445    0.0000 N   0  0  0  0  0  0  0  0  0  5  0  0
    0.7615   -2.9599    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
    2.8810   -2.7050    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    3.4941   -3.2570    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
    3.0525   -1.8980    0.0000 N   0  0  0  0  0  0  0  0  0  9  0  0
    3.8372   -1.6431    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    4.0087   -0.8361    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    4.7933   -0.5812    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    5.4064   -1.1332    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    5.2349   -1.9402    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    4.4502   -2.1951    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    6.1910   -0.8783    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    6.9756   -0.6233    0.0000 F   0  0  0  0  0  0  0  0  0 17  0  0
    6.4460   -1.6629    0.0000 F   0  0  0  0  0  0  0  0  0 18  0  0
    5.9361   -0.0936    0.0000 F   0  0  0  0  0  0  0  0  0 19  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  2  6  1  0
  3  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 10 15  1  0
 13 16  1  0
 16 17  1  0
 16 18  1  0
 16 19  1  0
M  END
>  <Name>  (9) 
Leflunomide

>  <InChIKey>  (9) 
VHOGYURTWQBHIL-UHFFFAOYSA-N

>  <PubChem_CID>  (9) 
3899

>  <CYP1A2>  (9) 
<5,6;Cleavage;R1>

>  <CYP2A6>  (9) 


>  <CYP2B6>  (9) 


>  <CYP2C8>  (9) 


>  <CYP2C9>  (9) 
<18,19;Cleavage;R1>
<17,18;Oxidation;R1>

>  <CYP2C19>  (9) 


>  <CYP2D6>  (9) 


>  <CYP2E1>  (9) 


>  <CYP3A4>  (9) 
<18,19;Cleavage;R1>
<17,18;Oxidation;R1>

>  <References>  (9) 
Wang B, Zhou SF: Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr Med Chem. 2009;16(31):4066-218. (PMID: 19754423)

>  <Comments>  (9) 


$$$$
CC02490
     RDKit          2D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -0.3984    0.7541    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -0.1435   -0.0305    0.0000 N   0  0  0  0  0  0  0  0  0  2  0  0
   -0.6284   -0.6979    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -0.1435   -1.3654    0.0000 N   0  0  0  0  0  0  0  0  0  4  0  0
    0.6411   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    0.6411   -0.2854    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    1.3556    0.1271    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    1.3556    0.9521    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
    2.0701   -0.2854    0.0000 N   0  0  0  0  0  0  0  0  0  9  0  0
    2.0701   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    2.7845   -1.5229    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
    1.3556   -1.5229    0.0000 N   0  0  0  0  0  0  0  0  0 12  0  0
    2.7845    0.1271    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  2  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
  5 12  1  0
  9 13  1  0
M  END
>  <Name>  (10) 
Paraxanthine

>  <InChIKey>  (10) 
QUNWUDVFRNGTCO-UHFFFAOYSA-N

>  <PubChem_CID>  (10) 
4687

>  <CYP1A2>  (10) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2A6>  (10) 


>  <CYP2B6>  (10) 


>  <CYP2C8>  (10) 


>  <CYP2C9>  (10) 


>  <CYP2C19>  (10) 


>  <CYP2D6>  (10) 


>  <CYP2E1>  (10) 


>  <CYP3A4>  (10) 


>  <References>  (10) 
Rost KL, Roots I: Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: coincidence with plasma clearance and breath test. Clin Pharmacol Ther. 1994 Apr;55(4):402-11. doi: 10.1038/clpt.1994.49. (PMID: 8162667)
Wang B, Zhou SF: Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr Med Chem. 2009;16(31):4066-218. (PMID: 19754423)

>  <Comments>  (10) 


$$$$
CC02491
     RDKit          2D

 19 20  0  0  0  0  0  0  0  0999 V2000
   -1.4289   -4.1250    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -1.4289   -3.3000    0.0000 O   0  0  0  0  0  0  0  0  0  2  0  0
   -0.7145   -2.8875    0.0000 P   0  0  0  0  0  0  0  0  0  3  0  0
   -0.3020   -3.6020    0.0000 S   0  0  0  0  0  0  0  0  0  4  0  0
   -1.1270   -2.1730    0.0000 O   0  0  0  0  0  0  0  0  0  5  0  0
   -0.7145   -1.4586    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    0.0000   -2.4750    0.0000 S   0  0  0  0  0  0  0  0  0  7  0  0
    0.0000   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    0.7145   -1.2375    0.0000 N   0  0  0  0  0  0  0  0  0  9  0  0
    0.7145   -0.4125    0.0000 N   0  0  0  0  0  0  0  0  0 10  0  0
    1.4289    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0 11  0  0
    2.1434   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    2.8579    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    3.5724   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    3.5724   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    2.8579   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    2.1434   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    1.4289   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    1.4289   -2.4750    0.0000 O   0  0  0  0  0  0  0  0  0 19  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  3  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 12 17  1  0
 17 18  1  0
  9 18  1  0
 18 19  2  0
M  END
>  <Name>  (11) 
Azinphos-methyl

>  <InChIKey>  (11) 
CJJOSEISRRTUQB-UHFFFAOYSA-N

>  <PubChem_CID>  (11) 
2268

>  <CYP1A2>  (11) 
<4,3;Desulfuration;R1>

>  <CYP2A6>  (11) 


>  <CYP2B6>  (11) 
<4,3;Desulfuration;R1>

>  <CYP2C8>  (11) 
<4,3;Desulfuration;R1>

>  <CYP2C9>  (11) 


>  <CYP2C19>  (11) 
<4,3;Desulfuration;R1>

>  <CYP2D6>  (11) 
<4,3;Desulfuration;R1>

>  <CYP2E1>  (11) 


>  <CYP3A4>  (11) 
<4,3;Desulfuration;R1>

>  <References>  (11) 
Buratti FM, Volpe MT, Fabrizi L, Meneguz A, Vittozzi L, Testai E: Kinetic parameters of OPT pesticide desulfuration by c-DNA expressed human CYPs. Environ Toxicol Pharmacol. 2002 Jul;11(3-4):181-90. (PMID: 21782601)
Hodgson E: In vitro human phase I metabolism of xenobiotics I: pesticides and related compounds used in agriculture and public health, May 2003. J Biochem Mol Toxicol. 2003;17(4):201-6. doi: 10.1002/jbt.10080. (PMID: 12898643)
Buratti FM, Volpe MT, Meneguz A, Vittozzi L, Testai E: CYP-specific bioactivation of four organophosphorothioate pesticides by human liver microsomes. Toxicol Appl Pharmacol. 2003 Feb 1;186(3):143-54. (PMID: 12620367)

>  <Comments>  (11) 


$$$$
CC02492
     RDKit          2D

 24 27  0  0  1  0  0  0  0  0999 V2000
    4.9279    4.4104    0.0000 F   0  0  0  0  0  0  0  0  0  1  0  0
    4.9279    3.5854    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    5.6424    3.1729    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    5.6424    2.3479    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    4.9279    1.9354    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    4.2135    2.3479    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    4.2135    3.1729    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    4.9279    1.1104    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    5.6424    0.6979    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    5.6424   -0.1271    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    4.9279   -0.5396    0.0000 N   0  0  0  0  0  0  0  0  0 11  0  0
    4.2135   -0.1271    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    4.2135    0.6979    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    3.4990    1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    2.7845    0.6979    0.0000 O   0  0  0  0  0  0  0  0  0 15  0  0
    2.0701    1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    1.3556    0.6979    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    0.6411    1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    0.6411    1.9354    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -0.1435    2.1904    0.0000 O   0  0  0  0  0  0  0  0  0 20  0  0
   -0.6284    1.5229    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -0.1435    0.8555    0.0000 O   0  0  0  0  0  0  0  0  0 22  0  0
    1.3556    2.3479    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    2.0701    1.9354    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  2  7  1  0
  8  5  1  6
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  8 13  1  0
 13 14  1  1
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 18 22  1  0
 19 23  1  0
 23 24  2  0
 16 24  1  0
M  END
>  <Name>  (12) 
Paroxetine

>  <InChIKey>  (12) 
AHOUBRCZNHFOSL-YOEHRIQHSA-N

>  <PubChem_CID>  (12) 
43815

>  <CYP1A2>  (12) 


>  <CYP2A6>  (12) 


>  <CYP2B6>  (12) 


>  <CYP2C8>  (12) 


>  <CYP2C9>  (12) 


>  <CYP2C19>  (12) 


>  <CYP2D6>  (12) 
<21,20;Cleavage;R1>
<21,22;Cleavage;R1>
<21,H;Oxidation;R1>

>  <CYP2E1>  (12) 


>  <CYP3A4>  (12) 


>  <References>  (12) 
Zhou SF: Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. Clin Pharmacokinet. 2009;48(11):689-723. doi: 10.2165/11318030-000000000-00000. (PMID: 19817501)
Zhou SF: Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin Pharmacokinet. 2009;48(12):761-804. doi: 10.2165/11318070-000000000-00000. (PMID: 19902987)

>  <Comments>  (12) 


$$$$
CC02493
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
   -0.6698    0.4143    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    0.0446    0.0018    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    0.0446   -0.8232    0.0000 N   0  0  0  0  0  0  0  0  0  3  0  0
   -0.6698   -1.2357    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -1.3843   -0.8232    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -1.3843    0.0018    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -2.2088    0.0306    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -2.6460   -0.6691    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -3.4705   -0.6403    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -3.8578    0.0882    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -3.4206    0.7878    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -2.5961    0.7590    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -4.6823    0.1170    0.0000 Br  0  0  0  0  0  0  0  0  0 13  0  0
   -1.8215    0.7014    0.0000 O   0  0  0  0  0  0  0  0  0 14  0  0
    0.7591   -1.2357    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    1.4736   -0.8232    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    2.1881   -1.2357    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    2.9025   -0.8232    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    2.9025    0.0018    0.0000 O   0  0  0  0  0  0  0  0  0 19  0  0
    3.6170   -1.2357    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    4.3315   -0.8232    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    5.0459   -1.2357    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    5.0459   -2.0607    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    4.3315   -2.4732    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
    3.6170   -2.0607    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    5.7604   -2.4732    0.0000 F   0  0  0  0  0  0  0  0  0 26  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
  7 12  1  0
 10 13  1  0
  6 14  1  0
  3 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 20 25  1  0
 23 26  1  0
M  END
>  <Name>  (13) 
Bromperidol

>  <InChIKey>  (13) 
RKLNONIVDFXQRX-UHFFFAOYSA-N

>  <PubChem_CID>  (13) 
2448

>  <CYP1A2>  (13) 


>  <CYP2A6>  (13) 


>  <CYP2B6>  (13) 


>  <CYP2C8>  (13) 


>  <CYP2C9>  (13) 


>  <CYP2C19>  (13) 


>  <CYP2D6>  (13) 


>  <CYP2E1>  (13) 


>  <CYP3A4>  (13) 
<3,4;Cleavage;R1>
<4,H;Oxidation;R1>

>  <References>  (13) 
Tateishi T, Watanabe M, Kumai T, Tanaka M, Moriya H, Yamaguchi S, Satoh T, Kobayashi S: CYP3A is responsible for N-dealkylation of haloperidol and bromperidol and oxidation of their reduced forms by human liver microsomes. Life Sci. 2000 Nov 3;67(24):2913-20. doi: 10.1016/s0024-3205(00)00874-2. (PMID: 11133003)

>  <Comments>  (13) 


$$$$
CC02494
     RDKit          2D

  6  5  0  0  0  0  0  0  0  0999 V2000
    1.2375    2.1434    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    0.8250    1.4289    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    1.2375    0.7145    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
    0.8250    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    1.2375   -0.7145    0.0000 N   0  0  0  0  0  0  0  0  0  5  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
M  END
>  <Name>  (14) 
Urethane

>  <InChIKey>  (14) 
JOYRKODLDBILNP-UHFFFAOYSA-N

>  <PubChem_CID>  (14) 
5641

>  <CYP1A2>  (14) 


>  <CYP2A6>  (14) 


>  <CYP2B6>  (14) 


>  <CYP2C8>  (14) 


>  <CYP2C9>  (14) 


>  <CYP2C19>  (14) 


>  <CYP2D6>  (14) 


>  <CYP2E1>  (14) 
<1,2;Dehydrogenation;R1>

>  <CYP3A4>  (14) 


>  <References>  (14) 
Rendic S, Guengerich FP: Contributions of human enzymes in carcinogen metabolism. Chem Res Toxicol. 2012 Jul 16;25(7):1316-83. doi: 10.1021/tx300132k. Epub 2012 May 10. (PMID: 22531028)

>  <Comments>  (14) 
Desaturation followed by epoxidation.

$$$$
CC02495
     RDKit          2D

  6  5  0  0  0  0  0  0  0  0999 V2000
    2.4750   -1.4289    0.0000 N   0  0  0  0  0  0  0  0  0  1  0  0
    2.0625   -0.7145    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    2.4750   -0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
    1.2375   -0.7145    0.0000 O   0  0  0  0  0  0  0  0  0  4  0  0
    0.8250    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
M  END
>  <Name>  (15) 
Vinyl carbamate

>  <InChIKey>  (15) 
LVLANIHJQRZTPY-UHFFFAOYSA-N

>  <PubChem_CID>  (15) 
27492

>  <CYP1A2>  (15) 


>  <CYP2A6>  (15) 


>  <CYP2B6>  (15) 


>  <CYP2C8>  (15) 


>  <CYP2C9>  (15) 


>  <CYP2C19>  (15) 


>  <CYP2D6>  (15) 


>  <CYP2E1>  (15) 
<5,6;EpOxidation;R1>

>  <CYP3A4>  (15) 


>  <References>  (15) 
Forkert PG, Lee RP, Reid K: Involvement of CYP2E1 and carboxylesterase enzymes in vinyl carbamate metabolism in human lung microsomes. Drug Metab Dispos. 2001 Mar;29(3):258-63. (PMID: 11181492)

>  <Comments>  (15) 


$$$$
CC02496
     RDKit          2D

 57 60  0  0  1  0  0  0  0  0999 V2000
    4.7187    1.4033    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    5.2907    0.8088    0.0000 O   0  0  0  0  0  0  0  0  0  2  0  0
    5.0619    0.0162    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    4.2611   -0.1820    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    4.0323   -0.9746    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    3.2314   -1.1728    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
    2.6594   -0.5783    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    2.4306   -1.3709    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    3.0026   -1.9654    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    1.6297   -1.5691    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    1.4009   -2.3617    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
    0.6001   -2.5599    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    0.0280   -1.9654    0.0000 O   0  0  0  0  0  0  0  0  0 13  0  0
   -0.7728   -2.1636    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -1.3449   -1.5691    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -1.0016   -2.9562    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -0.4296   -3.5507    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    0.3713   -3.3525    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    0.9433   -3.9470    0.0000 O   0  0  0  0  0  0  0  0  0 19  0  0
    1.7441   -3.7488    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    1.9729   -2.9562    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    2.3162   -4.3433    0.0000 O   0  0  0  0  0  0  0  0  0 22  0  0
   -0.6584   -4.3433    0.0000 N   0  0  0  0  0  0  0  0  0 23  0  0
   -0.0864   -4.9378    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -1.4593   -4.5415    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    1.0577   -0.9746    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
    0.2568   -1.1728    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
    1.2865   -0.1820    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
    0.7145    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
   -0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
    0.0000    0.8250    0.0000 O   0  0  0  0  0  0  0  0  0 31  0  0
    0.9433    1.2051    0.0000 C   0  0  0  0  0  0  0  0  0 32  0  0
    0.3713    1.7996    0.0000 O   0  0  0  0  0  0  0  0  0 33  0  0
    1.7441    1.4033    0.0000 C   0  0  0  0  0  0  0  0  0 34  0  0
    2.3162    0.8088    0.0000 C   0  0  0  0  0  0  0  0  0 35  0  0
    1.9729    2.1959    0.0000 C   0  0  0  0  0  0  0  0  0 36  0  0
    1.4009    2.7904    0.0000 O   0  0  0  0  0  0  0  0  0 37  0  0
    1.6297    3.5830    0.0000 C   0  0  0  0  0  0  0  0  0 38  0  0
    2.4306    3.7812    0.0000 C   0  0  0  0  0  0  0  0  0 39  0  0
    1.0577    4.1775    0.0000 O   0  0  0  0  0  0  0  0  0 40  0  0
    2.7738    2.3941    0.0000 C   0  0  0  0  0  0  0  0  0 41  0  0
    3.0026    3.1867    0.0000 C   0  0  0  0  0  0  0  0  0 42  0  0
    3.3458    1.7996    0.0000 C   0  0  0  0  0  0  0  0  0 43  0  0
    4.1467    1.9978    0.0000 C   0  0  0  0  0  0  0  0  0 44  0  0
    3.1170    1.0070    0.0000 O   0  0  0  0  0  0  0  0  0 45  0  0
    3.6891    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 46  0  0
    4.4899    0.6107    0.0000 O   0  0  0  0  0  0  0  0  0 47  0  0
    3.4602   -0.3801    0.0000 C   0  0  0  0  0  0  0  0  0 48  0  0
    4.2724   -0.5248    0.0000 C   0  0  0  0  0  0  0  0  0 49  0  0
    4.6043   -1.5691    0.0000 O   0  0  0  0  0  0  0  0  0 50  0  0
    5.4052   -1.3709    0.0000 C   0  0  0  0  0  0  0  0  0 51  0  0
    5.9772   -1.9654    0.0000 C   0  0  0  0  0  0  0  0  0 52  0  0
    5.6340   -0.5783    0.0000 C   0  0  0  0  0  0  0  0  0 53  0  0
    6.4348   -0.3801    0.0000 O   0  0  0  0  0  0  0  0  0 54  0  0
    6.6636    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 55  0  0
    6.0916    1.0070    0.0000 C   0  0  0  0  0  0  0  0  0 56  0  0
    7.4645    0.6107    0.0000 O   0  0  0  0  0  0  0  0  0 57  0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  4  5  1  0
  5  6  1  1
  7  6  1  6
  7  8  1  0
  8  9  1  6
  8 10  1  0
 10 11  1  1
 12 11  1  1
 12 13  1  0
 13 14  1  0
 14 15  1  1
 14 16  1  0
 16 17  1  0
 17 18  1  0
 12 18  1  0
 18 19  1  6
 19 20  1  0
 20 21  1  0
 20 22  2  0
 17 23  1  1
 23 24  1  0
 23 25  1  0
 10 26  1  0
 26 27  1  1
 26 28  1  0
 29 28  1  6
 29 30  1  0
 30 31  1  0
 29 31  1  0
 29 32  1  0
 32 33  2  0
 32 34  1  0
 34 35  1  1
 34 36  1  0
 36 37  1  1
 37 38  1  0
 38 39  1  0
 38 40  2  0
 36 41  1  0
 41 42  1  1
 41 43  1  0
 43 44  1  1
 43 45  1  0
 45 46  1  0
 46 47  2  0
 46 48  1  0
  7 48  1  0
 48 49  1  6
  5 50  1  0
 50 51  1  0
 51 52  1  6
 51 53  1  0
  3 53  1  0
 53 54  1  1
 54 55  1  0
 55 56  1  0
 55 57  2  0
M  END
>  <Name>  (16) 
Troleandomycin

>  <InChIKey>  (16) 
LQCLVBQBTUVCEQ-QTFUVMRISA-N

>  <PubChem_CID>  (16) 
202225

>  <CYP1A2>  (16) 


>  <CYP2A6>  (16) 


>  <CYP2B6>  (16) 


>  <CYP2C8>  (16) 


>  <CYP2C9>  (16) 


>  <CYP2C19>  (16) 


>  <CYP2D6>  (16) 


>  <CYP2E1>  (16) 


>  <CYP3A4>  (16) 
<18,19;Cleavage;R1>
<19,H;Oxidation;R1>
<18,20;Cleavage;R2>
<20,H;Oxidation;R2>

>  <References>  (16) 
Zanger UM, Schwab M: Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013 Apr;138(1):103-41. doi: 10.1016/j.pharmthera.2012.12.007. Epub 2013 Jan 16. (PMID: 23333322)
Rendic S, Di Carlo FJ: Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev. 1997 Feb-May;29(1-2):413-580. (PMID: 9187528)

>  <Comments>  (16) 


$$$$
CC02497
     RDKit          2D

 20 21  0  0  1  0  0  0  0  0999 V2000
   -5.4018   -1.3375    0.0000 N   0  0  0  0  0  0  0  0  0  1  0  0
   -6.1163   -0.9250    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -6.8307   -1.3375    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -6.8307   -2.1625    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -7.5452   -2.5750    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -8.2597   -2.1625    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -8.9741   -2.5750    0.0000 Cl  0  0  0  0  0  0  0  0  0  7  0  0
   -8.2597   -1.3375    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -7.5452   -0.9250    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -7.5452   -0.1000    0.0000 N   0  0  0  0  0  0  0  0  0 10  0  0
   -6.8307    0.3125    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -6.1163   -0.1000    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -4.6873   -0.9250    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -4.6873   -0.1000    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -3.9728   -1.3375    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -3.2584   -0.9250    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -2.5439   -1.3375    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -1.8294   -0.9250    0.0000 N   0  0  0  0  0  0  0  0  0 18  0  0
   -1.1150   -1.3375    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -0.4005   -0.9250    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  9  1  0
  3  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
  2 12  1  0
  1 13  1  0
 13 14  1  6
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
M  END
>  <Name>  (17) 
(R)-Desethylchloroquine

>  <InChIKey>  (17) 
MCYUUUTUAAGOOT-GFCCVEGCSA-N

>  <PubChem_CID>  (17) 
38989112

>  <CYP1A2>  (17) 


>  <CYP2A6>  (17) 


>  <CYP2B6>  (17) 


>  <CYP2C8>  (17) 
<19,18;Cleavage;R1>
<19,H;Oxidation;R1>

>  <CYP2C9>  (17) 


>  <CYP2C19>  (17) 


>  <CYP2D6>  (17) 
<19,18;Cleavage;R1>
<19,H;Oxidation;R1>

>  <CYP2E1>  (17) 


>  <CYP3A4>  (17) 
<19,18;Cleavage;R1>
<19,H;Oxidation;R1>

>  <References>  (17) 
Zanger UM, Schwab M: Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013 Apr;138(1):103-41. doi: 10.1016/j.pharmthera.2012.12.007. Epub 2013 Jan 16. (PMID: 23333322)
Rendic S: Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448. doi: 10.1081/DMR-120001392. (PMID: 11996015)

>  <Comments>  (17) 


$$$$
CC02498
     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
    9.0613    0.0488    0.0000 O   0  0  0  0  0  0  0  0  0  1  0  0
    8.2465    0.1778    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    7.7273   -0.4633    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    6.9124   -0.3343    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    6.6168    0.4359    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    7.1360    1.0771    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    7.9508    0.9480    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    8.4700    1.5892    0.0000 Cl  0  0  0  0  0  0  0  0  0  8  0  0
    5.8019    0.5650    0.0000 N   0  0  0  0  0  0  0  0  0  9  0  0
    5.2828   -0.0761    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    4.4679    0.0529    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    4.1723    0.8231    0.0000 N   0  0  0  0  0  0  0  0  0 12  0  0
    3.3574    0.9522    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    2.8382    0.3110    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    2.0234    0.4401    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    1.5042   -0.2011    0.0000 N   0  0  0  0  0  0  0  0  0 16  0  0
    1.7177   -0.9979    0.0000 N   0  0  0  0  0  0  0  0  0 17  0  0
    1.0258   -1.4473    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    0.3847   -0.9281    0.0000 N   0  0  0  0  0  0  0  0  0 19  0  0
    0.6803   -0.1579    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    0.2310    0.5340    0.0000 O   0  0  0  0  0  0  0  0  0 21  0  0
   -0.4122   -1.1416    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -0.9956   -0.5582    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -1.7925   -0.7718    0.0000 O   0  0  0  0  0  0  0  0  0 24  0  0
   -2.3758   -0.1884    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
   -3.1727   -0.4019    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -3.7561    0.1814    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
   -3.5426    0.9783    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
   -2.7457    1.1918    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
   -2.1623    0.6085    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
    0.9826   -2.2711    0.0000 C   0  0  0  0  0  0  0  0  0 31  0  0
    0.2476   -2.6457    0.0000 C   0  0  0  0  0  0  0  0  0 32  0  0
    4.6914    1.4643    0.0000 C   0  0  0  0  0  0  0  0  0 33  0  0
    5.5063    1.3352    0.0000 C   0  0  0  0  0  0  0  0  0 34  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  2  7  1  0
  7  8  1  0
  5  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 16 20  1  0
 20 21  2  0
 19 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 25 30  1  0
 18 31  1  0
 31 32  1  0
 12 33  1  0
 33 34  1  0
  9 34  1  0
M  END
>  <Name>  (18) 
p-Hydroxynefazodone

>  <InChIKey>  (18) 
XGIODORTBODPTQ-UHFFFAOYSA-N

>  <PubChem_CID>  (18) 
10435492

>  <CYP1A2>  (18) 


>  <CYP2A6>  (18) 


>  <CYP2B6>  (18) 


>  <CYP2C8>  (18) 


>  <CYP2C9>  (18) 


>  <CYP2C19>  (18) 


>  <CYP2D6>  (18) 


>  <CYP2E1>  (18) 


>  <CYP3A4>  (18) 
<1,2;Oxidation;R1>
<5,6;Oxidation;R1>
<4,5;EpOxidation;R2>

>  <References>  (18) 
Bolleddula J, DeMent K, Driscoll JP, Worboys P, Brassil PJ, Bourdet DL: Biotransformation and bioactivation reactions of alicyclic amines in drug molecules. Drug Metab Rev. 2014 Aug;46(3):379-419. doi: 10.3109/03602532.2014.924962. Epub 2014 Jun 9. (PMID: 24909234)

>  <Comments>  (18) 


$$$$
CC02499
     RDKit          2D

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.7145   -1.2375    0.0000 N   0  0  0  0  0  0  0  0  0  1  0  0
    1.5395   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    1.9520   -0.5230    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
    1.9520   -1.9520    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    2.7770   -1.9520    0.0000 N   0  0  0  0  0  0  0  0  0  5  0  0
    3.1895   -2.6664    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    4.0145   -2.6664    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    3.1895   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    4.0145   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    0.3020   -0.5230    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -0.5230   -0.5230    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -0.9355    0.1914    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -0.5230    0.9059    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    0.3020    0.9059    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    0.7145    1.6204    0.0000 O   0  0  0  0  0  0  0  0  0 15  0  0
    0.7145    0.1914    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    1.5395    0.1914    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -0.9355   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  1 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 10 16  1  0
 16 17  1  0
 11 18  1  0
M  END
>  <Name>  (19) 
3-Hydroxylidocaine

>  <InChIKey>  (19) 
PMGUCIDDSCRAMY-UHFFFAOYSA-N

>  <PubChem_CID>  (19) 
161824

>  <CYP1A2>  (19) 
<8,5;Cleavage;R1>
<8,H;Oxidation;R1>
<6,5;Cleavage;R2>
<6,H;Oxidation;R2>

>  <CYP2A6>  (19) 


>  <CYP2B6>  (19) 


>  <CYP2C8>  (19) 


>  <CYP2C9>  (19) 


>  <CYP2C19>  (19) 


>  <CYP2D6>  (19) 
<8,5;Cleavage;R1>
<8,H;Oxidation;R1>
<6,5;Cleavage;R2>
<6,H;Oxidation;R2>

>  <CYP2E1>  (19) 


>  <CYP3A4>  (19) 
<8,5;Cleavage;R1>
<8,H;Oxidation;R1>
<6,5;Cleavage;R2>
<6,H;Oxidation;R2>

>  <References>  (19) 
Zhou S (2016). Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism (1st ed.). CRC Press. (ISBN: 9781466597884)

>  <Comments>  (19) 


$$$$
CC02500
     RDKit          2D

 21 24  0  0  1  0  0  0  0  0999 V2000
    5.9401    1.6553    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    5.1517    1.8985    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    4.5470    1.3373    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    4.7305    0.5330    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    5.5189    0.2898    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    6.1237    0.8510    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    4.2162   -0.1120    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    3.3912   -0.1120    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
    2.8768    0.5330    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    3.0604    1.3373    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    2.4556    1.8985    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    1.6673    1.6553    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    1.4837    0.8510    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    0.6953    0.6078    0.0000 O   0  0  0  0  0  0  0  0  0 14  0  0
    2.0884    0.2898    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    3.8037    1.6953    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    2.9787   -0.8265    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    3.3912   -1.5409    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    4.2162   -1.5409    0.0000 N   0  0  0  0  0  0  0  0  0 19  0  0
    4.6287   -2.2554    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    4.6287   -0.8265    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  1  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
  9 15  1  0
 10 16  1  0
  3 16  1  0
  8 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
  7 21  1  6
M  END
>  <Name>  (20) 
(R)-8-Hydroxymianserin

>  <InChIKey>  (20) 
IXAPYQICIDTITB-SFHVURJKSA-N

>  <PubChem_CID>  (20) 


>  <CYP1A2>  (20) 
<20,19;Cleavage;R1>
<20,H;Oxidation;R1>

>  <CYP2A6>  (20) 


>  <CYP2B6>  (20) 


>  <CYP2C8>  (20) 


>  <CYP2C9>  (20) 


>  <CYP2C19>  (20) 


>  <CYP2D6>  (20) 
<20,19;Cleavage;R1>
<20,H;Oxidation;R1>

>  <CYP2E1>  (20) 


>  <CYP3A4>  (20) 
<20,19;Cleavage;R1>
<20,H;Oxidation;R1>

>  <References>  (20) 
Wang B, Zhou SF: Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr Med Chem. 2009;16(31):4066-218. (PMID: 19754423)

>  <Comments>  (20) 


$$$$
CC02501
     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
   -1.1810   -3.4491    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -0.7685   -2.7346    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    0.0565   -2.7346    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    0.4690   -3.4491    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    0.0565   -4.1636    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -0.7685   -4.1636    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    1.2940   -3.4491    0.0000 N   0  0  0  0  0  0  0  0  0  7  0  0
    1.7065   -2.7346    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    2.5315   -2.7346    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    2.9440   -2.0202    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    3.7690   -2.0202    0.0000 N   0  0  0  0  0  0  0  0  0 11  0  0
    4.1815   -1.3057    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    5.0065   -1.3057    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    4.1815   -2.7346    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    3.7690   -3.4491    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    1.7065   -4.1636    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    2.5270   -4.2498    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    2.6985   -5.0568    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    3.4130   -5.4693    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    3.4130   -6.2943    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    2.6985   -6.7068    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    1.9840   -6.2943    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    1.9840   -5.4693    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    1.3709   -4.9173    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  1  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
 14 15  1  0
  7 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 18 23  1  0
 23 24  1  0
 16 24  1  0
M  END
>  <Name>  (21) 
Aprindine

>  <InChIKey>  (21) 
NZLBHDRPUJLHCE-UHFFFAOYSA-N

>  <PubChem_CID>  (21) 
2218

>  <CYP1A2>  (21) 


>  <CYP2A6>  (21) 


>  <CYP2B6>  (21) 


>  <CYP2C8>  (21) 


>  <CYP2C9>  (21) 


>  <CYP2C19>  (21) 


>  <CYP2D6>  (21) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>
<9,12;Cleavage;R2>
<12,H;Oxidaiton;R2>

>  <CYP2E1>  (21) 


>  <CYP3A4>  (21) 


>  <References>  (21) 
Walraven JM, Trent JO, Hein DW: Structure-function analyses of single nucleotide polymorphisms in human N-acetyltransferase 1. Drug Metab Rev. 2008;40(1):169-84. doi: 10.1080/03602530701852917. (PMID: 18259988)

>  <Comments>  (21) 


$$$$
CC02502
     RDKit          2D

 26 27  0  0  0  0  0  0  0  0999 V2000
    0.4275    1.2927    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    0.1574    2.0723    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    0.6975    2.6959    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    1.5077    2.5400    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    1.9063    3.2623    0.0000 O   0  0  0  0  0  0  0  0  0  5  0  0
    1.3425    3.8646    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    2.0005    4.3624    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    0.9163    4.5710    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    0.5955    3.5146    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    1.7777    1.7605    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    2.5878    1.6046    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
    2.8579    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    2.3178    0.2014    0.0000 O   0  0  0  0  0  0  0  0  0 13  0  0
    3.6680    0.6691    0.0000 N   0  0  0  0  0  0  0  0  0 14  0  0
    3.9381   -0.1105    0.0000 S   0  0  0  0  0  0  0  0  0 15  0  0
    4.7482   -0.2664    0.0000 N   0  0  0  0  0  0  0  0  0 16  0  0
    5.0182   -1.0459    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    5.8284   -1.2018    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    6.0984   -1.9814    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    6.9086   -2.1373    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    5.2883    0.3573    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    6.0984    0.2014    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    6.6385    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    7.4486    0.6691    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
    4.2081    1.2927    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    1.2376    1.1368    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  6  9  1  0
  3  9  1  0
  4 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 16 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 14 25  1  0
 10 26  2  0
  1 26  1  0
M  END
>  <Name>  (22) 
Carbosulfan

>  <InChIKey>  (22) 
JLQUFIHWVLZVTJ-UHFFFAOYSA-N

>  <PubChem_CID>  (22) 
41384

>  <CYP1A2>  (22) 
<9,10;Cleavage;R1>

>  <CYP2A6>  (22) 
<9,10;Cleavage;R1>

>  <CYP2B6>  (22) 
<9,10;Cleavage;R1>
<10,S;S-Oxidation;R2>

>  <CYP2C8>  (22) 
<9,10;Cleavage;R1>

>  <CYP2C9>  (22) 


>  <CYP2C19>  (22) 
<9,10;Cleavage;R1>
<10,S;S-Oxidation;R2>

>  <CYP2D6>  (22) 


>  <CYP2E1>  (22) 


>  <CYP3A4>  (22) 
<9,10;Cleavage;R1>
<10,S;S-Oxidation;R2>

>  <References>  (22) 
Abass K, Reponen P, Mattila S, Pelkonen O: Metabolism of carbosulfan II. Human interindividual variability in its in vitro hepatic biotransformation and the identification of the cytochrome P450 isoforms involved. Chem Biol Interact. 2010 May 14;185(3):163-73. doi: 10.1016/j.cbi.2010.03.024. Epub 2010 Mar 20. (PMID: 20307514)

>  <Comments>  (22) 


$$$$
CC02503
     RDKit          2D

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.7145    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    1.4289    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    2.1434    1.2375    0.0000 Cl  0  0  0  0  0  0  0  0  0  3  0  0
    1.4289   -0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    2.1434   -0.4125    0.0000 O   0  0  0  0  0  0  0  0  0  5  0  0
    2.1434   -1.2375    0.0000 P   0  0  0  0  0  0  0  0  0  6  0  0
    1.3184   -1.2375    0.0000 O   0  0  0  0  0  0  0  0  0  7  0  0
    2.1434   -2.0625    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
    2.8579   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    2.8579   -3.3000    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    2.9684   -1.2375    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
    3.3809   -1.9520    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    4.2059   -1.9520    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    0.7145   -0.4125    0.0000 N   0  0  0  0  0  0  0  0  0 14  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -0.7145   -0.4125    0.0000 Cl  0  0  0  0  0  0  0  0  0 16  0  0
    0.0000    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -0.7145    1.2375    0.0000 Cl  0  0  0  0  0  0  0  0  0 18  0  0
  1  2  2  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
  6 11  1  0
 11 12  1  0
 12 13  1  0
  4 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
  1 17  1  0
 17 18  1  0
M  END
>  <Name>  (23) 
Chlorpyrifos oxon

>  <InChIKey>  (23) 
OTMOUPHCTWPNSL-UHFFFAOYSA-N

>  <PubChem_CID>  (23) 
21804

>  <CYP1A2>  (23) 


>  <CYP2A6>  (23) 


>  <CYP2B6>  (23) 
<5,6;Cleavage;R1>

>  <CYP2C8>  (23) 


>  <CYP2C9>  (23) 


>  <CYP2C19>  (23) 
<5,6;Cleavage;R1>

>  <CYP2D6>  (23) 


>  <CYP2E1>  (23) 


>  <CYP3A4>  (23) 
<5,6;Cleavage;R1>

>  <References>  (23) 
Brown CM, Reisfeld B, Mayeno AN: Cytochromes P450: a structure-based summary of biotransformations using representative substrates. Drug Metab Rev. 2008;40(1):1-100. doi: 10.1080/03602530802309742. (PMID: 18259985)

>  <Comments>  (23) 


$$$$
CC02504
     RDKit          2D

 21 21  0  0  1  0  0  0  0  0999 V2000
   -0.7145    4.5375    0.0000 N   0  0  0  0  0  0  0  0  0  1  0  0
   -0.7145    5.3625    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    0.0000    4.1250    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    0.0000    3.3000    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    0.7145    2.8875    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    0.7145    2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -0.1105    2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -0.9355    2.0625    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
    0.7145    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    1.4289    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    1.4289   -0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    0.7145   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    0.7145   -1.2375    0.0000 O   0  0  0  0  0  0  0  0  0 13  0  0
    1.4289   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -0.7145   -0.4125    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
   -1.4289    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    0.0000    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    1.5395    2.0625    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    1.9520    1.3480    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    1.9520    2.7770    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
  1  2  1  0
  1  3  1  0
  3  4  1  0
  4  5  1  0
  6  5  1  1
  6  7  1  0
  7  8  3  0
  6  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 12 15  1  0
 15 16  1  0
 16 17  1  0
 15 18  2  0
  9 18  1  0
  6 19  1  0
 19 20  1  0
 19 21  1  0
M  END
>  <Name>  (24) 
D-617

>  <InChIKey>  (24) 
WLOBUUJURNEQCL-QGZVFWFLSA-N

>  <PubChem_CID>  (24) 
13537153

>  <CYP1A2>  (24) 


>  <CYP2A6>  (24) 


>  <CYP2B6>  (24) 


>  <CYP2C8>  (24) 


>  <CYP2C9>  (24) 


>  <CYP2C19>  (24) 


>  <CYP2D6>  (24) 


>  <CYP2E1>  (24) 


>  <CYP3A4>  (24) 
<2,1;Cleavage;R1>
<2,H;Oxidation;R1>

>  <References>  (24) 
Brown CM, Reisfeld B, Mayeno AN: Cytochromes P450: a structure-based summary of biotransformations using representative substrates. Drug Metab Rev. 2008;40(1):1-100. doi: 10.1080/03602530802309742. (PMID: 18259985)
Tracy TS, Korzekwa KR, Gonzalez FJ, Wainer IW: Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil. Br J Clin Pharmacol. 1999 May;47(5):545-52. doi: 10.1046/j.1365-2125.1999.00923.x. (PMID: 10336579)
Wang B, Zhou SF: Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr Med Chem. 2009;16(31):4066-218. (PMID: 19754423)

>  <Comments>  (24) 


$$$$
CC02505
     RDKit          2D

 12 11  0  0  0  0  0  0  0  0999 V2000
    0.8250    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  1  0  0
    1.2375   -0.7145    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    0.8250   -1.4289    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
    2.0625   -0.7145    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    2.4750   -1.4289    0.0000 S   0  0  0  0  0  0  0  0  0  5  0  0
    3.3000   -1.4289    0.0000 P   0  0  0  0  0  0  0  0  0  6  0  0
    3.3000   -2.2539    0.0000 S   0  0  0  0  0  0  0  0  0  7  0  0
    4.1250   -1.4289    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
    4.5375   -2.1434    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    3.3000   -0.6039    0.0000 O   0  0  0  0  0  0  0  0  0 10  0  0
    4.0145   -0.1914    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -0.0670   -0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  6 10  1  0
 10 11  1  0
  1 12  1  0
M  END
>  <Name>  (25) 
Dimethoate

>  <InChIKey>  (25) 
MCWXGJITAZMZEV-UHFFFAOYSA-N

>  <PubChem_CID>  (25) 
3082

>  <CYP1A2>  (25) 
<7,6;Desulfuration;R1>

>  <CYP2A6>  (25) 
<7,6;Desulfuration;R1>

>  <CYP2B6>  (25) 
<7,6;Desulfuration;R1>

>  <CYP2C8>  (25) 
<7,6;Desulfuration;R1>

>  <CYP2C9>  (25) 
<7,6;Desulfuration;R1>

>  <CYP2C19>  (25) 
<7,6;Desulfuration;R1>

>  <CYP2D6>  (25) 


>  <CYP2E1>  (25) 


>  <CYP3A4>  (25) 
<7,6;Desulfuration;R1>

>  <References>  (25) 
Buratti FM, Testai E: Evidences for CYP3A4 autoactivation in the desulfuration of dimethoate by the human liver. Toxicology. 2007 Nov 20;241(1-2):33-46. doi: 10.1016/j.tox.2007.08.081. Epub 2007 Aug 6. (PMID: 17897769)

>  <Comments>  (25) 


$$$$
CC02506
     RDKit          2D

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.7145    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    1.4289    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    2.1434    1.2375    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
    2.1434    2.0625    0.0000 P   0  0  0  0  0  0  0  0  0  4  0  0
    2.9684    2.0625    0.0000 O   0  0  0  0  0  0  0  0  0  5  0  0
    2.1434    2.8875    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
    2.8579    3.3000    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    2.8579    4.1250    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    1.3184    2.0625    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
    0.9059    2.7770    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    1.3184    3.4914    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    1.4289   -0.0000    0.0000 N   0  0  0  0  0  0  0  0  0 12  0  0
    0.7145   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0 14  0  0
    0.0000    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -0.7145    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    0.7145   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    1.4289   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -0.0000   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  4  9  1  0
  9 10  1  0
 10 11  1  0
  2 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
  1 15  1  0
 15 16  1  0
 13 17  1  0
 17 18  1  0
 17 19  1  0
M  END
>  <Name>  (26) 
Diazoxon

>  <InChIKey>  (26) 
VBLJFQYCTRKKKF-UHFFFAOYSA-N

>  <PubChem_CID>  (26) 
13754

>  <CYP1A2>  (26) 


>  <CYP2A6>  (26) 


>  <CYP2B6>  (26) 


>  <CYP2C8>  (26) 


>  <CYP2C9>  (26) 


>  <CYP2C19>  (26) 
<4,3;Cleavage;R1>

>  <CYP2D6>  (26) 


>  <CYP2E1>  (26) 


>  <CYP3A4>  (26) 


>  <References>  (26) 
Kappers WA, Edwards RJ, Murray S, Boobis AR: Diazinon is activated by CYP2C19 in human liver. Toxicol Appl Pharmacol. 2001 Nov 15;177(1):68-76. doi: 10.1006/taap.2001.9294. (PMID: 11708902)
Buratti FM, Volpe MT, Meneguz A, Vittozzi L, Testai E: CYP-specific bioactivation of four organophosphorothioate pesticides by human liver microsomes. Toxicol Appl Pharmacol. 2003 Feb 1;186(3):143-54. (PMID: 12620367)

>  <Comments>  (26) 


$$$$
CC02507
     RDKit          2D

 14 13  0  0  0  0  0  0  0  0999 V2000
    5.3625   -3.5724    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    4.9500   -2.8579    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    4.1250   -2.8579    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
    3.7125   -2.1434    0.0000 P   0  0  0  0  0  0  0  0  0  4  0  0
    4.4270   -1.7309    0.0000 S   0  0  0  0  0  0  0  0  0  5  0  0
    2.9980   -2.5559    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
    2.2836   -2.1434    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    1.5691   -2.5559    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    3.3000   -1.4289    0.0000 S   0  0  0  0  0  0  0  0  0  9  0  0
    2.4750   -1.4289    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    2.0625   -0.7145    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    1.2375   -0.7145    0.0000 S   0  0  0  0  0  0  0  0  0 12  0  0
    0.8250    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  4  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
M  END
>  <Name>  (27) 
Disulfoton

>  <InChIKey>  (27) 
DOFZAZXDOSGAJZ-UHFFFAOYSA-N

>  <PubChem_CID>  (27) 
3118

>  <CYP1A2>  (27) 
<12,S;S-Oxidation;R1>

>  <CYP2A6>  (27) 


>  <CYP2B6>  (27) 
<12,S;S-Oxidation;R1>

>  <CYP2C8>  (27) 


>  <CYP2C9>  (27) 
<12,S;S-Oxidation;R1>

>  <CYP2C19>  (27) 
<12,S;S-Oxidation;R1>

>  <CYP2D6>  (27) 
<12,S;S-Oxidation;R1>

>  <CYP2E1>  (27) 


>  <CYP3A4>  (27) 
<12,S;S-Oxidation;R1>

>  <References>  (27) 
Usmani KA, Karoly ED, Hodgson E, Rose RL: In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily. Drug Metab Dispos. 2004 Mar;32(3):333-9. doi: 10.1124/dmd.32.3.333. (PMID: 14977868)

>  <Comments>  (27) 


$$$$
CC02508
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -0.5837   -5.6992    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -1.4087   -5.6992    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -1.8212   -4.9848    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -1.4087   -4.2703    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -0.5837   -4.2703    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -0.1712   -4.9848    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -1.8212   -3.5558    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -1.4087   -2.8414    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
   -1.8212   -2.1269    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -1.4087   -1.4124    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -0.5837   -1.4124    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -0.1712   -0.6979    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    0.6538   -0.6979    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    1.1387   -0.0305    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    0.8838    0.7541    0.0000 O   0  0  0  0  0  0  0  0  0 15  0  0
    1.9233   -0.2854    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    2.6378    0.1271    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    3.3523   -0.2854    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    4.0668    0.1271    0.0000 O   0  0  0  0  0  0  0  0  0 19  0  0
    4.0668    0.9521    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    3.3523   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    4.0668   -1.5229    0.0000 O   0  0  0  0  0  0  0  0  0 22  0  0
    4.0668   -2.3479    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    2.6378   -1.5229    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
    1.9233   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    1.1387   -1.3654    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -0.1712   -2.1269    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
   -0.5837   -2.8414    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  1  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 18 21  2  0
 21 22  1  0
 22 23  1  0
 21 24  1  0
 24 25  2  0
 16 25  1  0
 25 26  1  0
 13 26  1  0
 11 27  1  0
 27 28  1  0
  8 28  1  0
M  END
>  <Name>  (28) 
Donepezil

>  <InChIKey>  (28) 
ADEBPBSSDYVVLD-UHFFFAOYSA-N

>  <PubChem_CID>  (28) 
3152

>  <CYP1A2>  (28) 


>  <CYP2A6>  (28) 


>  <CYP2B6>  (28) 


>  <CYP2C8>  (28) 


>  <CYP2C9>  (28) 
<20,21;Cleavage;R1>
<21,H;Oxidation;R1>
<5,6;Cleavage;R2>
<6,H;Oxidation;R2>
<17,18;Cleavage;R3>
<18,H;Oxidation;R3>

>  <CYP2C19>  (28) 


>  <CYP2D6>  (28) 
<20,21;Cleavage;R1>
<21,H;Oxidation;R1>

>  <CYP2E1>  (28) 


>  <CYP3A4>  (28) 
<20,21;Cleavage;R1>
<21,H;Oxidation;R1>
<5,6;Cleavage;R2>
<6,H;Oxidation;R2>
<17,18;Cleavage;R3>
<18,H;Oxidation;R3>

>  <References>  (28) 
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (28) 


$$$$
CC02509
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
   -2.8579   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -2.1434   -2.8875    0.0000 O   0  0  0  0  0  0  0  0  0  2  0  0
   -2.1434   -3.7125    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -1.4289   -4.1250    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -1.4289   -4.9500    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -2.1434   -5.3625    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -2.8579   -4.9500    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -2.8579   -4.1250    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -2.1434   -6.1875    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -1.4289   -6.6000    0.0000 O   0  0  0  0  0  0  0  0  0 10  0  0
   -2.8579   -6.6000    0.0000 N   0  0  0  0  0  0  0  0  0 11  0  0
   -2.8579   -7.4250    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -2.1434   -7.8375    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -2.1434   -8.6625    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -2.8579   -9.0750    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -3.5724   -8.6625    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -3.5724   -7.8375    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -4.2868   -7.4250    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -5.0013   -7.8375    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -5.0013   -8.6625    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -4.2868   -9.0750    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -4.2868   -9.9000    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -5.0013  -10.3125    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -5.7158   -9.9000    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -5.7158   -9.0750    0.0000 N   0  0  0  0  0  0  0  0  0 25  0  0
   -6.4302   -8.6625    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  3  8  1  0
  6  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 12 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 20 25  1  0
 25 26  1  0
M  END
>  <Name>  (29) 
Encainide

>  <InChIKey>  (29) 
PJWPNDMDCLXCOM-UHFFFAOYSA-N

>  <PubChem_CID>  (29) 
48041

>  <CYP1A2>  (29) 


>  <CYP2A6>  (29) 


>  <CYP2B6>  (29) 


>  <CYP2C8>  (29) 


>  <CYP2C9>  (29) 


>  <CYP2C19>  (29) 


>  <CYP2D6>  (29) 
<23,24;Cleavage;R1>
<24,H;Oxidation;R1>
<1,2;Cleavage;R2>
<1,H;Oxidation;R2>

>  <CYP2E1>  (29) 


>  <CYP3A4>  (29) 


>  <References>  (29) 
Zhou S (2016). Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism (1st ed.). CRC Press. (ISBN: 9781466597884)

>  <Comments>  (29) 


$$$$
CC02510
     RDKit          2D

 21 23  0  0  0  0  0  0  0  0999 V2000
   -3.3367    3.8358    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -4.1251    3.5927    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -4.3087    2.7884    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -3.7039    2.2272    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -2.9155    2.4704    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -2.7320    3.2747    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -2.2339    2.0056    0.0000 N   0  0  0  0  0  0  0  0  0  7  0  0
   -2.1722    1.1830    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -2.7770    0.6218    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -2.5934   -0.1825    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -1.8051   -0.4257    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -1.2003    0.1355    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -0.4120   -0.1077    0.0000 Cl  0  0  0  0  0  0  0  0  0 13  0  0
   -1.3839    0.9398    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -3.5928    0.7448    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -4.0053    1.4592    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -1.5194    2.4181    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -0.8050    2.0056    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -0.0905    2.4181    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    0.6240    2.0056    0.0000 N   0  0  0  0  0  0  0  0  0 20  0  0
    1.3385    2.4181    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  1  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
  8 14  1  0
  9 15  1  0
 15 16  1  0
  4 16  1  0
  7 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
M  END
>  <Name>  (30) 
N-Desmethylclomipramine

>  <InChIKey>  (30) 
VPIXQGUBUKFLRF-UHFFFAOYSA-N

>  <PubChem_CID>  (30) 
622606

>  <CYP1A2>  (30) 
<11,12;Cleavage;R1>
<12,H;Oxidation;R1>

>  <CYP2A6>  (30) 


>  <CYP2B6>  (30) 


>  <CYP2C8>  (30) 


>  <CYP2C9>  (30) 


>  <CYP2C19>  (30) 
<11,12;Cleavage;R1>
<12,H;Oxidation;R1>

>  <CYP2D6>  (30) 


>  <CYP2E1>  (30) 


>  <CYP3A4>  (30) 
<11,12;Cleavage;R1>
<12,H;Oxidation;R1>

>  <References>  (30) 
Wang B, Zhou SF: Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr Med Chem. 2009;16(31):4066-218. (PMID: 19754423)

>  <Comments>  (30) 


$$$$
CC02511
     RDKit          2D

 25 27  0  0  1  0  0  0  0  0999 V2000
   -7.5673   -1.8946    0.0000 N   0  0  0  0  0  0  0  0  0  1  0  0
   -8.2818   -2.3071    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -8.9963   -1.8946    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
   -8.2818   -3.1321    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -7.5673   -3.5446    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -7.5673   -4.3696    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -8.2818   -4.7821    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -8.2818   -5.6071    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
   -8.9963   -6.0196    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -8.9963   -4.3696    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -8.9963   -3.5446    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -7.5673   -1.0696    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -8.2818   -0.6571    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -8.2818    0.1679    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -7.5673    0.5804    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -6.8529    0.1679    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -6.8529   -0.6571    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -6.1384   -1.0696    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -5.4239   -0.6571    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -5.4239    0.1679    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -6.1384    0.5804    0.0000 N   0  0  0  0  0  0  0  0  0 21  0  0
   -6.1384    1.4054    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -5.4239    1.8179    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -4.7095    1.4054    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -4.7095    0.5804    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  7 10  1  0
 10 11  2  0
  4 11  1  0
  1 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 12 17  1  0
 17 18  1  0
 18 19  1  0
 20 19  1  1
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 20 25  1  0
M  END
>  <Name>  (31) 
N-Demethylencainide

>  <InChIKey>  (31) 
QLMVRMLCNYDKJN-SFHVURJKSA-N

>  <PubChem_CID>  (31) 
101663689

>  <CYP1A2>  (31) 


>  <CYP2A6>  (31) 


>  <CYP2B6>  (31) 


>  <CYP2C8>  (31) 


>  <CYP2C9>  (31) 


>  <CYP2C19>  (31) 


>  <CYP2D6>  (31) 
<9,8;Cleavage;R1>
<9,H;Oxidation;R1>

>  <CYP2E1>  (31) 


>  <CYP3A4>  (31) 


>  <References>  (31) 
Zhou S (2016). Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism (1st ed.). CRC Press. (ISBN: 9781466597884)

>  <Comments>  (31) 


$$$$
CC02512
     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
   -0.8692    0.3241    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -0.8692   -0.5009    0.0000 N   0  0  0  0  0  0  0  0  0  2  0  0
   -0.1548   -0.9134    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -0.1548   -1.7384    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -0.8692   -2.1509    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -1.5837   -1.7384    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -1.5837   -0.9134    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -2.2982   -0.5009    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -2.2982    0.3241    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -3.0127    0.7366    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -3.7271    0.3241    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -4.4416    0.7366    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -4.4416    1.5616    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -3.7271    1.9741    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -3.0127    1.5616    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -2.2982    1.9741    0.0000 N   0  0  0  0  0  0  0  0  0 16  0  0
   -2.2982    2.7991    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -3.0127    3.2116    0.0000 O   0  0  0  0  0  0  0  0  0 18  0  0
   -1.5837    3.2116    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -1.5837    4.0366    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -0.8692    4.4491    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -0.1548    4.0366    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    0.5597    4.4491    0.0000 O   0  0  0  0  0  0  0  0  0 23  0  0
   -0.1548    3.2116    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -0.8692    2.7991    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  2  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 10 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 22 24  1  0
 24 25  2  0
 19 25  1  0
M  END
>  <Name>  (32) 
O-Demethylencainide

>  <InChIKey>  (32) 
QMHJFCPHRGVEAF-UHFFFAOYSA-N

>  <PubChem_CID>  (32) 
54736

>  <CYP1A2>  (32) 


>  <CYP2A6>  (32) 


>  <CYP2B6>  (32) 


>  <CYP2C8>  (32) 


>  <CYP2C9>  (32) 


>  <CYP2C19>  (32) 


>  <CYP2D6>  (32) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2E1>  (32) 


>  <CYP3A4>  (32) 


>  <References>  (32) 
Zhou S (2016). Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism (1st ed.). CRC Press. (ISBN: 9781466597884)

>  <Comments>  (32) 


$$$$
CC02513
     RDKit          2D

 16 16  0  0  0  0  0  0  0  0999 V2000
   -4.7989    2.0187    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -4.0845    1.6062    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -3.3700    2.0187    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
   -3.3700    2.8437    0.0000 P   0  0  0  0  0  0  0  0  0  4  0  0
   -2.5450    2.8437    0.0000 S   0  0  0  0  0  0  0  0  0  5  0  0
   -3.3700    3.6687    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
   -2.6555    4.0812    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -4.1950    2.8437    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
   -4.6075    3.5582    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -4.0845    0.7812    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -4.7989    0.3687    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -5.5134    0.7812    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -6.2279    0.3687    0.0000 S   0  0  0  0  0  0  0  0  0 13  0  0
   -6.2279   -0.4563    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -5.5134    1.6062    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -4.7989   -0.4563    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  4  8  1  0
  8  9  1  0
  2 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 12 15  2  0
  1 15  1  0
 11 16  1  0
M  END
>  <Name>  (33) 
Fenthion

>  <InChIKey>  (33) 
PNVJTZOFSHSLTO-UHFFFAOYSA-N

>  <PubChem_CID>  (33) 
3346

>  <CYP1A2>  (33) 
<5,4;Desulfuration;R1>

>  <CYP2A6>  (33) 


>  <CYP2B6>  (33) 
<5,4;Desulfuration;R1>

>  <CYP2C8>  (33) 


>  <CYP2C9>  (33) 
<5,4;Desulfuration;R1>

>  <CYP2C19>  (33) 
<5,4;Desulfuration;R1>

>  <CYP2D6>  (33) 


>  <CYP2E1>  (33) 


>  <CYP3A4>  (33) 
<5,4;Desulfuration;R1>

>  <References>  (33) 
Leoni C, Buratti FM, Testai E: The participation of human hepatic P450 isoforms, flavin-containing monooxygenases and aldehyde oxidase in the biotransformation of the insecticide fenthion. Toxicol Appl Pharmacol. 2008 Dec 1;233(2):343-52. doi: 10.1016/j.taap.2008.09.004. Epub 2008 Sep 19. (PMID: 18845175)

>  <Comments>  (33) 


$$$$
CC02514
     RDKit          2D

 28 29  0  0  1  0  0  0  0  0999 V2000
   -7.2995    1.5848    0.0000 N   0  0  0  0  0  0  0  0  0  1  0  0
   -8.0139    1.1723    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -8.7284    1.5848    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
   -8.0139    0.3473    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -7.2995   -0.0652    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -7.2995   -0.8902    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -6.5850   -1.3027    0.0000 O   0  0  0  0  0  0  0  0  0  7  0  0
   -6.5850   -2.1277    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -5.8705   -2.5402    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -5.1561   -2.9527    0.0000 F   0  0  0  0  0  0  0  0  0 10  0  0
   -5.4580   -1.8257    0.0000 F   0  0  0  0  0  0  0  0  0 11  0  0
   -6.2830   -3.2546    0.0000 F   0  0  0  0  0  0  0  0  0 12  0  0
   -8.0139   -1.3027    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -8.7284   -0.8902    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -8.7284   -0.0652    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -9.4429    0.3473    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
   -9.4429    1.1723    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
  -10.1574    1.5848    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -9.7449    2.2993    0.0000 F   0  0  0  0  0  0  0  0  0 19  0  0
  -10.5699    0.8704    0.0000 F   0  0  0  0  0  0  0  0  0 20  0  0
  -10.8718    1.9973    0.0000 F   0  0  0  0  0  0  0  0  0 21  0  0
   -7.2995    2.4098    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -8.0139    2.8223    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -8.7284    2.4098    0.0000 N   0  0  0  0  0  0  0  0  0 24  0  0
   -9.4429    2.8223    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
   -9.4429    3.6473    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -8.7284    4.0598    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
   -8.0139    3.6473    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
  9 12  1  0
  6 13  2  0
 13 14  1  0
 14 15  2  0
  4 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 18 21  1  0
  1 22  1  0
 23 22  1  1
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 23 28  1  0
M  END
>  <Name>  (34) 
Flecainide

>  <InChIKey>  (34) 
DJBNUMBKLMJRSA-NSHDSACASA-N

>  <PubChem_CID>  (34) 
6604414

>  <CYP1A2>  (34) 


>  <CYP2A6>  (34) 


>  <CYP2B6>  (34) 


>  <CYP2C8>  (34) 


>  <CYP2C9>  (34) 


>  <CYP2C19>  (34) 


>  <CYP2D6>  (34) 
<17,16;Cleavage;R1>
<17,H;Oxidation;R1>

>  <CYP2E1>  (34) 


>  <CYP3A4>  (34) 


>  <References>  (34) 
Zhou S (2016). Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism (1st ed.). CRC Press. (ISBN: 9781466597884)

>  <Comments>  (34) 


$$$$
CC02516
     RDKit          2D

 23 26  0  0  1  0  0  0  0  0999 V2000
   -2.8207   -0.5585    0.0000 O   0  0  0  0  0  0  0  0  0  1  0  0
   -2.5008   -1.3814    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -3.3129   -1.2362    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -4.1250   -1.0910    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -2.7301   -2.1739    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -2.0473   -2.6369    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -1.3959   -2.1305    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -0.5838   -2.2757    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -0.3035   -3.0516    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    0.5086   -3.1969    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    1.0404   -2.5662    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    0.7601   -1.7902    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    1.2920   -1.1595    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    2.1041   -1.3047    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    2.3844   -2.0807    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    3.1965   -2.2259    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
    3.7283   -1.5952    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    1.8526   -2.7114    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -0.0520   -1.6450    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -0.3323   -0.8691    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -1.1444   -0.7239    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -1.6762   -1.3546    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -1.8575   -0.6122    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
  2  1  1  6
  2  3  1  0
  3  4  3  0
  2  5  1  0
  5  6  1  0
  7  6  1  6
  7  8  1  0
  8  9  1  1
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 15 18  2  0
 11 18  1  0
 12 19  1  0
  8 19  1  0
 19 20  1  6
 20 21  1  0
 21 22  1  0
  2 22  1  0
  7 22  1  0
 22 23  1  6
M  END
>  <Name>  (35) 
Mestranol

>  <InChIKey>  (35) 
IMSSROKUHAOUJS-MJCUULBUSA-N

>  <PubChem_CID>  (35) 
6291

>  <CYP1A2>  (35) 


>  <CYP2A6>  (35) 


>  <CYP2B6>  (35) 


>  <CYP2C8>  (35) 


>  <CYP2C9>  (35) 
<17,16;Cleavage;R1>
<17,H;Oxidation;R1>

>  <CYP2C19>  (35) 


>  <CYP2D6>  (35) 


>  <CYP2E1>  (35) 


>  <CYP3A4>  (35) 


>  <References>  (35) 
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (35) 


$$$$
CC02517
     RDKit          2D

 31 35  0  0  1  0  0  0  0  0999 V2000
   -5.6996   -3.8802    0.0000 O   0  0  0  0  0  0  0  0  0  1  0  0
   -5.7592   -3.0574    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -6.1918   -3.2026    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -7.0039   -3.3478    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -7.8161   -3.4930    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -5.6090   -2.2649    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -4.9262   -1.8019    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -4.2748   -2.3082    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -3.4627   -2.1630    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -2.9309   -2.7937    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -2.1188   -2.6485    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -1.8385   -1.8726    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -1.0264   -1.7274    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -0.4945   -2.3581    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    0.3176   -2.2129    0.0000 O   0  0  0  0  0  0  0  0  0 15  0  0
   -0.7748   -3.1340    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -1.5870   -3.2792    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -2.3703   -1.2419    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -3.1824   -1.3871    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -3.2112   -3.5697    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -2.6794   -4.2004    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -1.8673   -4.0551    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -1.3354   -4.6859    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -1.6157   -5.4618    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -1.0839   -6.0925    0.0000 N   0  0  0  0  0  0  0  0  0 25  0  0
   -1.3642   -6.8684    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -2.4279   -5.6070    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
   -2.9597   -4.9763    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
   -4.0233   -3.7149    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
   -4.5551   -3.0842    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
   -4.7588   -3.9158    0.0000 C   0  0  0  0  0  0  0  0  0 31  0  0
  2  1  1  1
  2  3  1  0
  3  4  3  0
  4  5  1  0
  2  6  1  0
  6  7  1  0
  8  7  1  1
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 11 17  1  0
 12 18  1  0
 18 19  1  0
  9 19  1  6
 10 20  1  0
 20 21  1  1
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 24 27  1  0
 27 28  2  0
 21 28  1  0
 20 29  1  0
 29 30  1  0
  2 30  1  0
  8 30  1  0
 30 31  1  1
M  END
>  <Name>  (36) 
Monodemethylated mifepristone

>  <InChIKey>  (36) 
IBLXOBHABOVXDY-WKWWZUSTSA-N

>  <PubChem_CID>  (36) 
10070462

>  <CYP1A2>  (36) 


>  <CYP2A6>  (36) 


>  <CYP2B6>  (36) 


>  <CYP2C8>  (36) 


>  <CYP2C9>  (36) 


>  <CYP2C19>  (36) 


>  <CYP2D6>  (36) 


>  <CYP2E1>  (36) 


>  <CYP3A4>  (36) 
<26,25;Cleavage;R1>
<26,H;Oxidation;R1>

>  <References>  (36) 
Brown CM, Reisfeld B, Mayeno AN: Cytochromes P450: a structure-based summary of biotransformations using representative substrates. Drug Metab Rev. 2008;40(1):1-100. doi: 10.1080/03602530802309742. (PMID: 18259985)
Khan KK, He YQ, Domanski TL, Halpert JR: Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: an evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation. Mol Pharmacol. 2002 Mar;61(3):495-506. doi: 10.1124/mol.61.3.495. (PMID: 11854429)
Randall J: Potential interferences in carbon monoxide sensor performance from ethyl alcohol. AIHA J (Fairfax, Va). 2002 Mar-Apr;63(2):130; author reply 130. (PMID: 11996017)

>  <Comments>  (36) 


$$$$
CC02518
     RDKit          2D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -3.7052   -0.3446    0.0000 N   0  0  0  0  0  0  0  0  0  1  0  0
   -2.9907    0.0679    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -2.9907    0.8929    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
   -2.2762   -0.3446    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -1.5618    0.0679    0.0000 N   0  0  0  0  0  0  0  0  0  5  0  0
   -0.8473   -0.3446    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -0.1328    0.0679    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -4.4196    0.0679    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -5.1341   -0.3446    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -5.8486    0.0679    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -5.8486    0.8929    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -5.1341    1.3054    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -4.4196    0.8929    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -3.7052    1.3054    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -5.1341   -1.1696    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  1  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  8 13  1  0
 13 14  1  0
  9 15  1  0
M  END
>  <Name>  (37) 
Monoethylglycinexylidide

>  <InChIKey>  (37) 
WRMRXPASUROZGT-UHFFFAOYSA-N

>  <PubChem_CID>  (37) 
24415

>  <CYP1A2>  (37) 
<6,5;Cleavage;R1>
<6,H;Oxidation;R1>

>  <CYP2A6>  (37) 


>  <CYP2B6>  (37) 


>  <CYP2C8>  (37) 


>  <CYP2C9>  (37) 


>  <CYP2C19>  (37) 


>  <CYP2D6>  (37) 


>  <CYP2E1>  (37) 


>  <CYP3A4>  (37) 
<6,5;Cleavage;R1>
<6,H;Oxidation;R1>

>  <References>  (37) 
Zhou S (2016). Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism (1st ed.). CRC Press. (ISBN: 9781466597884)

>  <Comments>  (37) 


$$$$
CC02519
     RDKit          2D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -5.9602    0.6027    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -5.2457    1.0152    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -4.5313    0.6027    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -4.5313   -0.2223    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -5.2457   -0.6348    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -5.9602   -0.2223    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -3.8168   -0.6348    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -3.1023   -0.2223    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
   -2.3878   -0.6348    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -1.6734   -0.2223    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -0.9589   -0.6348    0.0000 N   0  0  0  0  0  0  0  0  0 11  0  0
   -0.2444   -0.2223    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -3.8168   -1.4598    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -3.1023   -1.8723    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -3.1023   -2.6973    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -3.8168   -3.1098    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -4.5313   -2.6973    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -4.5313   -1.8723    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  1  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  7 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 13 18  1  0
M  END
>  <Name>  (38) 
N-Desmethyldiphenhydramine

>  <InChIKey>  (38) 
AGSLYHYWLYGAOU-UHFFFAOYSA-N

>  <PubChem_CID>  (38) 
40791

>  <CYP1A2>  (38) 
<12,11;Cleavage;R1>
<12,H;Oxidation;R1>

>  <CYP2A6>  (38) 


>  <CYP2B6>  (38) 


>  <CYP2C8>  (38) 


>  <CYP2C9>  (38) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <CYP2C19>  (38) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <CYP2D6>  (38) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <CYP2E1>  (38) 


>  <CYP3A4>  (38) 


>  <References>  (38) 
Wang B, Zhou SF: Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr Med Chem. 2009;16(31):4066-218. (PMID: 19754423)

>  <Comments>  (38) 


$$$$
CC02520
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   -6.3622   -0.7911    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -7.0766   -0.3786    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -7.0766    0.4464    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -6.3622    0.8589    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -5.6477    0.4464    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -5.6477   -0.3786    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -6.3622    1.6839    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -7.0766    2.0964    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -7.0766    2.9214    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -7.7911    3.3339    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -7.7911    4.1589    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -7.0766    4.5714    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -6.3622    4.1589    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -6.3622    3.3339    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -7.7911    1.6839    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -8.5056    2.0964    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -5.6477    2.0964    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -5.6477    2.9214    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -4.9332    3.3339    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -4.2188    2.9214    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -3.5043    3.3339    0.0000 O   0  0  0  0  0  0  0  0  0 21  0  0
   -2.7898    2.9214    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -2.0753    3.3339    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -1.3609    2.9214    0.0000 N   0  0  0  0  0  0  0  0  0 24  0  0
   -0.6464    3.3339    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
   -4.2188    2.0964    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -4.9332    1.6839    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  1  6  1  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  9 14  1  0
  8 15  1  0
 15 16  1  0
  7 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 20 26  1  0
 26 27  2  0
 17 27  1  0
M  END
>  <Name>  (39) 
N-Desmethyltamoxifen

>  <InChIKey>  (39) 
NYDCDZSEEAUOHN-IZHYLOQSSA-N

>  <PubChem_CID>  (39) 
6378383

>  <CYP1A2>  (39) 


>  <CYP2A6>  (39) 


>  <CYP2B6>  (39) 


>  <CYP2C8>  (39) 


>  <CYP2C9>  (39) 


>  <CYP2C19>  (39) 


>  <CYP2D6>  (39) 


>  <CYP2E1>  (39) 


>  <CYP3A4>  (39) 
<22,23;Cleavage;R1>
<23,H;Oxidation;R1>

>  <References>  (39) 
Brown CM, Reisfeld B, Mayeno AN: Cytochromes P450: a structure-based summary of biotransformations using representative substrates. Drug Metab Rev. 2008;40(1):1-100. doi: 10.1080/03602530802309742. (PMID: 18259985)
Wang B, Zhou SF: Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr Med Chem. 2009;16(31):4066-218. (PMID: 19754423)
Zhou SF: Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin Pharmacokinet. 2009;48(12):761-804. doi: 10.2165/11318070-000000000-00000. (PMID: 19902987)
Rendic S: Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448. doi: 10.1081/DMR-120001392. (PMID: 11996015)

>  <Comments>  (39) 


$$$$
CC02521
     RDKit          2D

 20 21  0  0  1  0  0  0  0  0999 V2000
   -5.4018   -1.3375    0.0000 N   0  0  0  0  0  0  0  0  0  1  0  0
   -6.1163   -0.9250    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -6.8307   -1.3375    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -6.8307   -2.1625    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -7.5452   -2.5750    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -8.2597   -2.1625    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -8.9741   -2.5750    0.0000 Cl  0  0  0  0  0  0  0  0  0  7  0  0
   -8.2597   -1.3375    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -7.5452   -0.9250    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -7.5452   -0.1000    0.0000 N   0  0  0  0  0  0  0  0  0 10  0  0
   -6.8307    0.3125    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -6.1163   -0.1000    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -4.6873   -0.9250    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -4.6873   -0.1000    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -3.9728   -1.3375    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -3.2584   -0.9250    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -2.5439   -1.3375    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -1.8294   -0.9250    0.0000 N   0  0  0  0  0  0  0  0  0 18  0  0
   -1.1150   -1.3375    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -0.4005   -0.9250    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  9  1  0
  3  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
  2 12  1  0
  1 13  1  0
 13 14  1  6
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
M  END
>  <Name>  (40) 
Monodesethylchloroquine

>  <InChIKey>  (40) 
MCYUUUTUAAGOOT-GFCCVEGCSA-N

>  <PubChem_CID>  (40) 
38989112

>  <CYP1A2>  (40) 


>  <CYP2A6>  (40) 


>  <CYP2B6>  (40) 


>  <CYP2C8>  (40) 


>  <CYP2C9>  (40) 


>  <CYP2C19>  (40) 


>  <CYP2D6>  (40) 
<19,18;Cleavage;R1>
<19,H;Oxidation;R1>

>  <CYP2E1>  (40) 


>  <CYP3A4>  (40) 


>  <References>  (40) 
Zanger UM, Schwab M: Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013 Apr;138(1):103-41. doi: 10.1016/j.pharmthera.2012.12.007. Epub 2013 Jan 16. (PMID: 23333322)
Rendic S: Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448. doi: 10.1081/DMR-120001392. (PMID: 11996015)

>  <Comments>  (40) 


$$$$
CC02522
     RDKit          2D

 33 34  0  0  1  0  0  0  0  0999 V2000
  -11.0058    1.3938    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
  -10.2913    0.9813    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -9.5768    1.3938    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
  -10.2913    0.1563    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -9.5768   -0.2562    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -8.8623    0.1563    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -8.1479   -0.2562    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -7.4334    0.1563    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -7.4334    0.9813    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
   -6.7189   -0.2562    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -6.0045    0.1563    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -6.0045    0.9813    0.0000 O   0  0  0  0  0  0  0  0  0 12  0  0
   -5.2900   -0.2562    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -4.5755    0.1563    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -3.8611   -0.2562    0.0000 O   0  0  0  0  0  0  0  0  0 15  0  0
   -4.5755    0.9813    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
   -9.5768   -1.0812    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
  -10.2913   -1.4937    0.0000 N   0  0  0  0  0  0  0  0  0 18  0  0
  -11.0058   -1.0812    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
  -11.0058   -0.2562    0.0000 N   0  0  0  0  0  0  0  0  0 20  0  0
  -11.7202   -1.4937    0.0000 N   0  0  0  0  0  0  0  0  0 21  0  0
  -12.4347   -1.0812    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
  -11.7202   -2.3187    0.0000 S   0  0  0  0  0  0  0  0  0 23  0  0
  -11.7202   -3.1437    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
  -12.5452   -2.3187    0.0000 O   0  0  0  0  0  0  0  0  0 25  0  0
  -10.8952   -2.3187    0.0000 O   0  0  0  0  0  0  0  0  0 26  0  0
   -8.8623   -1.4937    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
   -8.1479   -1.0812    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
   -7.4334   -1.4937    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
   -7.4334   -2.3187    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
   -6.7189   -2.7312    0.0000 F   0  0  0  0  0  0  0  0  0 31  0  0
   -8.1479   -2.7312    0.0000 C   0  0  0  0  0  0  0  0  0 32  0  0
   -8.8623   -2.3187    0.0000 C   0  0  0  0  0  0  0  0  0 33  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  6
  8 10  1  0
 10 11  1  0
 11 12  1  6
 11 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
  5 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
  4 20  1  0
 19 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 23 25  2  0
 23 26  2  0
 17 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 30 32  1  0
 32 33  2  0
 27 33  1  0
M  END
>  <Name>  (41) 
Rosuvastatin

>  <InChIKey>  (41) 
BPRHUIZQVSMCRT-RJCHQFKYSA-N

>  <PubChem_CID>  (41) 
12136803

>  <CYP1A2>  (41) 


>  <CYP2A6>  (41) 


>  <CYP2B6>  (41) 


>  <CYP2C8>  (41) 


>  <CYP2C9>  (41) 
<27,28;Cleavage;R1>
<28,H;Oxidation;R1>

>  <CYP2C19>  (41) 
<27,28;Cleavage;R1>
<28,H;Oxidation;R1>

>  <CYP2D6>  (41) 


>  <CYP2E1>  (41) 


>  <CYP3A4>  (41) 


>  <References>  (41) 
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (41) 


$$$$
CC02523
     RDKit          2D

 35 39  0  0  1  0  0  0  0  0999 V2000
  -10.7379   -2.1732    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
  -10.0234   -1.7607    0.0000 O   0  0  0  0  0  0  0  0  0  2  0  0
  -10.0234   -0.9357    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
  -10.7379   -0.5232    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
  -11.4524   -0.9357    0.0000 O   0  0  0  0  0  0  0  0  0  5  0  0
  -10.7379    0.3018    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
  -10.0234    0.7143    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -9.3090    0.3018    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -9.3090   -0.5232    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -8.5945    0.7143    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -7.8800    0.3018    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
   -7.1655    0.7143    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -7.1655    1.5393    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -7.8800    1.9518    0.0000 O   0  0  0  0  0  0  0  0  0 14  0  0
   -8.5945    1.5393    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -9.3090    1.9518    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
  -10.0234    1.5393    0.0000 O   0  0  0  0  0  0  0  0  0 17  0  0
   -6.4511    1.9518    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -5.7366    1.5393    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -5.7366    0.7143    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -6.4511    0.3018    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -5.0221    0.3018    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -4.3077    0.7143    0.0000 O   0  0  0  0  0  0  0  0  0 23  0  0
   -3.5932    0.3018    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -2.8787    0.7143    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
   -2.1643    0.3018    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -1.4498    0.7143    0.0000 O   0  0  0  0  0  0  0  0  0 27  0  0
   -2.1643   -0.5232    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
   -2.8787   -0.9357    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
   -2.8787   -1.7607    0.0000 O   0  0  0  0  0  0  0  0  0 30  0  0
   -3.5932   -0.5232    0.0000 C   0  0  0  0  0  0  0  0  0 31  0  0
   -4.3077   -0.9357    0.0000 C   0  0  0  0  0  0  0  0  0 32  0  0
   -4.3077   -1.7607    0.0000 O   0  0  0  0  0  0  0  0  0 33  0  0
   -5.0221   -0.5232    0.0000 C   0  0  0  0  0  0  0  0  0 34  0  0
   -5.7366   -0.9357    0.0000 O   0  0  0  0  0  0  0  0  0 35  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  3  9  1  0
 10  8  1  6
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 10 15  1  0
 15 16  1  1
 16 17  1  0
 13 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 12 21  1  0
 22 20  1  1
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
 28 29  1  0
 29 30  1  0
 29 31  2  0
 24 31  1  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 22 34  1  0
 34 35  1  6
M  END
>  <Name>  (42) 
Silybin 

>  <InChIKey>  (42) 
SEBFKMXJBCUCAI-HKTJVKLFSA-N

>  <PubChem_CID>  (42) 
31553

>  <CYP1A2>  (42) 


>  <CYP2A6>  (42) 


>  <CYP2B6>  (42) 


>  <CYP2C8>  (42) 
<1,2;Cleavage;R1>
<2,H;Oxidation;R1>
<1,4;Cleavage;R1>
<4,H;Oxidation;R1>

>  <CYP2C9>  (42) 


>  <CYP2C19>  (42) 


>  <CYP2D6>  (42) 


>  <CYP2E1>  (42) 


>  <CYP3A4>  (42) 


>  <References>  (42) 
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (42) 


$$$$
CC02524
     RDKit          2D

 23 24  0  0  0  0  0  0  0  0999 V2000
   -8.6834   -1.3813    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -7.9689   -1.7938    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -7.9689   -2.6188    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -8.6834   -3.0313    0.0000 N   0  0  0  0  0  0  0  0  0  4  0  0
   -9.3979   -2.6188    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
  -10.1123   -3.0313    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
  -10.8268   -2.6188    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -9.3979   -1.7938    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -7.2545   -3.0313    0.0000 N   0  0  0  0  0  0  0  0  0  9  0  0
   -6.5400   -2.6188    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -6.5400   -1.7938    0.0000 S   0  0  0  0  0  0  0  0  0 11  0  0
   -5.8255   -3.0313    0.0000 O   0  0  0  0  0  0  0  0  0 12  0  0
   -5.1111   -2.6188    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -5.1111   -1.7938    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -4.3966   -1.3813    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -3.6821   -1.7938    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -3.6821   -2.6188    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -4.3966   -3.0313    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -2.9676   -3.0313    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -2.2532   -3.4438    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -3.3801   -3.7457    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -2.5551   -2.3168    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -7.2545   -3.8563    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  2  0
  1  8  1  0
  3  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 13 18  1  0
 17 19  1  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
  9 23  1  0
M  END
>  <Name>  (43) 
Pyributicarb

>  <InChIKey>  (43) 
VTRWMTJQBQJKQH-UHFFFAOYSA-N

>  <PubChem_CID>  (43) 
93486

>  <CYP1A2>  (43) 


>  <CYP2A6>  (43) 


>  <CYP2B6>  (43) 


>  <CYP2C8>  (43) 


>  <CYP2C9>  (43) 


>  <CYP2C19>  (43) 
<21,22;Cleavage;R1>
<22,H;Oxidation;R1>

>  <CYP2D6>  (43) 


>  <CYP2E1>  (43) 


>  <CYP3A4>  (43) 


>  <References>  (43) 
Ohkawa H, Inui H: Metabolism of agrochemicals and related environmental chemicals based on cytochrome P450s in mammals and plants. Pest Manag Sci. 2015 Jun;71(6):824-8. doi: 10.1002/ps.3871. Epub 2014 Nov 19. (PMID: 25077812)

>  <Comments>  (43) 


$$$$
CC02525
     RDKit          2D

 18 18  0  0  1  0  0  0  0  0999 V2000
   -5.9150    1.4830    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -5.2005    1.0705    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -5.2005    0.2455    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -4.4861   -0.1670    0.0000 S   0  0  0  0  0  0  0  0  0  4  0  0
   -4.4861   -0.9920    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -5.9150   -0.1670    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -6.6295    0.2455    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -6.6295    1.0705    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -7.3439    1.4830    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
   -7.3439    2.3080    0.0000 P   0  0  0  0  0  0  0  0  0 10  0  0
   -6.5189    2.3080    0.0000 S   0  0  0  0  0  0  0  0  0 11  0  0
   -8.1689    2.3080    0.0000 O   0  0  0  0  0  0  0  0  0 12  0  0
   -8.5814    3.0225    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -9.4064    3.0225    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -7.3439    3.1330    0.0000 S   0  0  0  0  0  0  0  0  0 15  0  0
   -8.0584    3.5455    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -8.0584    4.3705    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -8.7729    4.7830    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  2  0
  6  7  1  0
  7  8  2  0
  1  8  1  0
  8  9  1  0
 10  9  1  6
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 10 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
M  END
>  <Name>  (44) 
Sulprofos

>  <InChIKey>  (44) 
JXHJNEJVUNHLKO-HNNXBMFYSA-N

>  <PubChem_CID>  (44) 
38988334

>  <CYP1A2>  (44) 
<4,S;S-Oxidation;R1>

>  <CYP2A6>  (44) 


>  <CYP2B6>  (44) 


>  <CYP2C8>  (44) 


>  <CYP2C9>  (44) 
<4,S;S-Oxidation;R1>

>  <CYP2C19>  (44) 
<4,S;S-Oxidation;R1>

>  <CYP2D6>  (44) 
<4,S;S-Oxidation;R1>

>  <CYP2E1>  (44) 


>  <CYP3A4>  (44) 
<4,S;S-Oxidation;R1>

>  <References>  (44) 
Usmani KA, Karoly ED, Hodgson E, Rose RL: In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily. Drug Metab Dispos. 2004 Mar;32(3):333-9. doi: 10.1124/dmd.32.3.333. (PMID: 14977868)

>  <Comments>  (44) 


$$$$
CC02526
     RDKit          2D

 11 11  0  0  0  0  0  0  0  0999 V2000
   -7.2543    2.6652    0.0000 O   0  0  0  0  0  0  0  0  0  1  0  0
   -7.2543    1.8402    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -6.5398    1.4277    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -6.5398    0.6027    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -7.2543    0.1902    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -7.9687    0.6027    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -7.9687    1.4277    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -8.6832    1.8402    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -9.3977    1.4277    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -8.6832    2.6652    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -5.8253    0.1902    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  2  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
  4 11  1  0
M  END
>  <Name>  (45) 
Thymol

>  <InChIKey>  (45) 
MGSRCZKZVOBKFT-UHFFFAOYSA-N

>  <PubChem_CID>  (45) 
6989

>  <CYP1A2>  (45) 
<9,11;Dehydrogenation;R1>
<9,10;Dehydrogenation;R2>

>  <CYP2A6>  (45) 
<9,11;Dehydrogenation;R1>
<9,10;Dehydrogenation;R2>

>  <CYP2B6>  (45) 


>  <CYP2C8>  (45) 


>  <CYP2C9>  (45) 


>  <CYP2C19>  (45) 


>  <CYP2D6>  (45) 
<9,11;Dehydrogenation;R1>
<9,10;Dehydrogenation;R2>

>  <CYP2E1>  (45) 


>  <CYP3A4>  (45) 


>  <References>  (45) 
Jager W, Hoferl M (2015). Metabolism of Terpenoids in Animal Models and Humans. In Handbook of Essential Oils: Science, Technology, and Applications (2nd ed., pp. 253-279). CRC Press. (ISBN: 9781466590465)

>  <Comments>  (45) 


$$$$
CC02527
     RDKit          2D

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.7660    2.2688    0.0000 O   0  0  0  0  0  0  0  0  0  1  0  0
   -0.0223    2.0256    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -0.2059    1.2213    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
   -0.6271    2.5867    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -1.4154    2.3436    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -2.0202    2.9047    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -2.8085    2.6615    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -2.9921    1.8572    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -3.7354    1.4993    0.0000 S   0  0  0  0  0  0  0  0  0  9  0  0
   -4.4787    1.8572    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -5.0835    1.2961    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -5.8718    1.5393    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -6.0554    2.3436    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -5.4506    2.9047    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -4.6623    2.6615    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -4.1479    3.3066    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -4.5059    4.0498    0.0000 O   0  0  0  0  0  0  0  0  0 17  0  0
   -3.3229    3.3066    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -2.3873    1.2961    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -1.5990    1.5393    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -0.4435    3.3911    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 10 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
  7 18  1  0
  8 19  1  0
 19 20  2  0
  5 20  1  0
  4 21  1  0
M  END
>  <Name>  (46) 
Zaltoprofen

>  <InChIKey>  (46) 
MUXFZBHBYYYLTH-UHFFFAOYSA-N

>  <PubChem_CID>  (46) 
5720

>  <CYP1A2>  (46) 


>  <CYP2A6>  (46) 


>  <CYP2B6>  (46) 


>  <CYP2C8>  (46) 


>  <CYP2C9>  (46) 
<18,19;Reduction;R1>
<11,S;S-Oxidation;R2>

>  <CYP2C19>  (46) 


>  <CYP2D6>  (46) 


>  <CYP2E1>  (46) 


>  <CYP3A4>  (46) 


>  <References>  (46) 
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (46) 


$$$$
CC02528
     RDKit          2D

 30 34  0  0  1  0  0  0  0  0999 V2000
    0.2716   -9.9932    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -0.5130   -9.7382    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -0.6846   -8.9313    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -0.0715   -8.3792    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    0.7132   -8.6342    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    0.8847   -9.4412    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    1.1981   -7.9667    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    2.0231   -7.9667    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
    0.7132   -7.2993    0.0000 N   0  0  0  0  0  0  0  0  0  9  0  0
   -0.0715   -7.5542    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -0.7389   -7.0693    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
    0.9681   -6.5147    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    0.4161   -5.9016    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    0.6710   -5.1170    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    0.1190   -4.5039    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    0.3739   -3.7192    0.0000 N   0  0  0  0  0  0  0  0  0 16  0  0
   -0.1781   -3.1062    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    0.0768   -2.3215    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    0.8838   -2.1500    0.0000 N   0  0  0  0  0  0  0  0  0 19  0  0
    1.4358   -2.7631    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    1.1809   -3.5477    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    1.1387   -1.3654    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    0.6538   -0.6979    0.0000 N   0  0  0  0  0  0  0  0  0 23  0  0
    1.1387   -0.0305    0.0000 S   0  0  0  0  0  0  0  0  0 24  0  0
    1.9233   -0.2854    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    2.6378    0.1271    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
    3.3523   -0.2854    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
    3.3523   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
    2.6378   -1.5229    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
    1.9233   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
  1  2  1  0
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  6
  1  6  1  0
  5  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
  4 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 16 21  1  0
 19 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 25 30  1  0
 22 30  1  0
M  END
>  <Name>  (47) 
Perospirone

>  <InChIKey>  (47) 
FBVFZWUMDDXLLG-HDICACEKSA-N

>  <PubChem_CID>  (47) 
115368

>  <CYP1A2>  (47) 


>  <CYP2A6>  (47) 


>  <CYP2B6>  (47) 


>  <CYP2C8>  (47) 
<13,14;Cleavage;R1>
<13,H;Oxidation;R1>
<1,H;Hydroxylation;R2>
<2,H;Hydroxylation;R3>
<4,H;Hydroxylation;R4>
<5,H;Hydroxylation;R5>

>  <CYP2C9>  (47) 


>  <CYP2C19>  (47) 


>  <CYP2D6>  (47) 
<1,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>

>  <CYP2E1>  (47) 


>  <CYP3A4>  (47) 
<4,5;Dehydrogenation;R1>
<13,14;Cleavage;R1>
<13,H;Oxidation;R1>
<4,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>

>  <References>  (47) 
Suzuki Y, Sawamura K, Ono S, Fukui N, Sugai T, Watanabe J, Tsuneyama N, Inoue Y, Someya T: The wide variability of perospirone metabolism and the effect of perospirone on prolactin in psychiatric patients. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):830-3. doi: 10.1016/j.pnpbp.2010.03.027. Epub 2010 Apr 2. (PMID: 20363276)

>  <Comments>  (47) 


$$$$
CC02529
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   -3.8080    1.6036    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -3.8080    0.7786    0.0000 N   0  0  0  0  0  0  0  0  0  2  0  0
   -3.0935    0.3661    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -3.0935   -0.4589    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -3.8080   -0.8714    0.0000 N   0  0  0  0  0  0  0  0  0  5  0  0
   -4.5225   -0.4589    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -4.5225    0.3661    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -3.8080   -1.6964    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -4.5225   -2.1089    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -4.5225   -2.9339    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -5.2370   -3.3464    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -5.2370   -4.1714    0.0000 N   0  0  0  0  0  0  0  0  0 12  0  0
   -4.5695   -4.6563    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -3.7849   -4.4014    0.0000 O   0  0  0  0  0  0  0  0  0 14  0  0
   -4.8245   -5.4409    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -5.6495   -5.4409    0.0000 N   0  0  0  0  0  0  0  0  0 16  0  0
   -5.9044   -4.6563    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -6.6890   -4.4014    0.0000 O   0  0  0  0  0  0  0  0  0 18  0  0
   -6.1344   -6.1084    0.0000 N   0  0  0  0  0  0  0  0  0 19  0  0
   -6.9549   -6.0221    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -7.4398   -6.6896    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -7.1848   -7.4742    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -7.8523   -7.9591    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -8.5197   -7.4742    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -8.2648   -6.6896    0.0000 O   0  0  0  0  0  0  0  0  0 25  0  0
   -9.3043   -7.7291    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -9.4759   -8.5361    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
  -10.2605   -8.7910    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
  -10.8736   -8.2390    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
  -10.7021   -7.4320    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
   -9.9174   -7.1771    0.0000 C   0  0  0  0  0  0  0  0  0 31  0  0
  -11.6582   -8.4940    0.0000 Cl  0  0  0  0  0  0  0  0  0 32  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  2  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 12 17  1  0
 17 18  2  0
 16 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 21 25  1  0
 24 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 26 31  1  0
 29 32  1  0
M  END
>  <Name>  (48) 
Azimilide

>  <InChIKey>  (48) 
MREBEPTUUMTTIA-PCLIKHOPSA-N

>  <PubChem_CID>  (48) 
9571004

>  <CYP1A2>  (48) 


>  <CYP2A6>  (48) 


>  <CYP2B6>  (48) 


>  <CYP2C8>  (48) 


>  <CYP2C9>  (48) 


>  <CYP2C19>  (48) 


>  <CYP2D6>  (48) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2E1>  (48) 


>  <CYP3A4>  (48) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,N;N-Oxidation;R2>

>  <References>  (48) 
Riley P, Figary PC, Entwisle JR, Roe AL, Thompson GA, Ohashi R, Ohashi N, Moorehead TJ: The metabolic profile of azimilide in man: in vivo and in vitro evaluations. J Pharm Sci. 2005 Sep;94(9):2084-95. doi: 10.1002/jps.20429. (PMID: 16052551)

>  <Comments>  (48) 


$$$$
CC02530
     RDKit          2D

 30 31  0  0  0  0  0  0  0  0999 V2000
   -6.8305    0.9929    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -7.5450    0.5804    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -7.5450   -0.2446    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -8.2595   -0.6571    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -8.9740   -0.2446    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -8.9740    0.5804    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -8.2595    0.9929    0.0000 N   0  0  0  0  0  0  0  0  0  7  0  0
   -9.6884    0.9929    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -9.6884   -0.6571    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -9.6884   -1.4821    0.0000 O   0  0  0  0  0  0  0  0  0 10  0  0
  -10.4029   -0.2446    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
  -11.1174   -0.6571    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
  -11.8318   -0.2446    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
  -11.1174   -1.4821    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -8.2595   -1.4821    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -7.5450   -1.8946    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -7.5450   -2.7196    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -8.2595   -3.1321    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -8.9740   -2.7196    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -8.9740   -1.8946    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -6.8305   -3.1321    0.0000 N   0  0  0  0  0  0  0  0  0 21  0  0
   -6.8305   -3.9571    0.0000 O   0  0  0  0  0  0  0  0  0 22  0  0
   -6.1161   -2.7196    0.0000 O   0  0  0  0  0  0  0  0  0 23  0  0
   -6.8305   -0.6571    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -6.8305   -1.4821    0.0000 O   0  0  0  0  0  0  0  0  0 25  0  0
   -6.1161   -0.2446    0.0000 O   0  0  0  0  0  0  0  0  0 26  0  0
   -5.4016   -0.6571    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
   -4.6871   -0.2446    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
   -3.9727   -0.6571    0.0000 O   0  0  0  0  0  0  0  0  0 29  0  0
   -3.2582   -0.2446    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  2  7  1  0
  6  8  1  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
  4 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 15 20  1  0
 17 21  1  0
 21 22  2  0
 21 23  1  0
  3 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
M  CHG  2  21   1  23  -1
M  END
>  <Name>  (49) 
Nimodipine

>  <InChIKey>  (49) 
UIAGMCDKSXEBJQ-UHFFFAOYSA-N

>  <PubChem_CID>  (49) 
4497

>  <CYP1A2>  (49) 


>  <CYP2A6>  (49) 


>  <CYP2B6>  (49) 


>  <CYP2C8>  (49) 


>  <CYP2C9>  (49) 


>  <CYP2C19>  (49) 


>  <CYP2D6>  (49) 


>  <CYP2E1>  (49) 


>  <CYP3A4>  (49) 
<11,H;Oxidation;R1>
<30,H;Oxidation;R1>
<10,9;Cleavage;R2>
<10,H;Oxidation;R2>

>  <References>  (49) 
Al-Omar MA: Nimodipine: drug metabolism and pharmacokinetic profile. Profiles Drug Subst Excip Relat Methodol. 2005;31:371-5. doi: 10.1016/S0099-5428(04)31011-7. (PMID: 22469047)

>  <Comments>  (49) 


$$$$
CC02531
     RDKit          2D

 28 29  0  0  0  0  0  0  0  0999 V2000
  -12.4813    0.9083    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
  -11.9421    0.2264    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
  -11.9557   -0.5985    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
  -11.2481   -1.0227    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
  -10.5270   -0.6220    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
  -10.5134    0.2028    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
  -11.2209    0.6271    0.0000 N   0  0  0  0  0  0  0  0  0  7  0  0
   -9.9315    0.8500    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -9.6484   -0.8725    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -9.2922   -1.6684    0.0000 O   0  0  0  0  0  0  0  0  0 10  0  0
   -8.7795   -0.6817    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
   -7.9703   -1.0186    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -7.1989   -0.6817    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -6.5349   -1.1713    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -7.1069    0.1382    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
  -11.2617   -1.8476    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
  -10.5542   -2.2718    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
  -10.5678   -3.0967    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
  -11.2889   -3.4974    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
  -11.9965   -3.0732    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
  -11.9829   -2.2483    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
  -12.9253   -2.1014    0.0000 N   0  0  0  0  0  0  0  0  0 22  0  0
  -13.3954   -1.3152    0.0000 O   0  0  0  0  0  0  0  0  0 23  0  0
  -13.7615   -2.4635    0.0000 O   0  0  0  0  0  0  0  0  0 24  0  0
  -12.8802   -0.6708    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
  -12.4301   -1.3964    0.0000 O   0  0  0  0  0  0  0  0  0 26  0  0
  -13.8684   -0.7209    0.0000 O   0  0  0  0  0  0  0  0  0 27  0  0
  -14.2442   -1.4553    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  2  7  1  0
  6  8  1  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
  4 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 16 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
  3 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
M  CHG  2  22   1  24  -1
M  END
>  <Name>  (50) 
Nisoldipine

>  <InChIKey>  (50) 
VKQFCGNPDRICFG-UHFFFAOYSA-N

>  <PubChem_CID>  (50) 
4499

>  <CYP1A2>  (50) 
<8,H;Oxidation;R1>
<28,H;Oxidation;R1>

>  <CYP2A6>  (50) 


>  <CYP2B6>  (50) 


>  <CYP2C8>  (50) 


>  <CYP2C9>  (50) 
<8,H;Oxidation;R1>
<28,H;Oxidation;R1>

>  <CYP2C19>  (50) 
<8,H;Oxidation;R1>
<28,H;Oxidation;R1>

>  <CYP2D6>  (50) 
<8,H;Oxidation;R1>
<28,H;Oxidation;R1>

>  <CYP2E1>  (50) 
<8,H;Oxidation;R1>
<28,H;Oxidation;R1>

>  <CYP3A4>  (50) 
<8,H;Oxidation;R1>
<28,H;Oxidation;R1>

>  <References>  (50) 
Komura H, Yasuda M, Yoshida NH, Sugiyama Y: Species difference in nisoldipine oxidation activity in the small intestine. Drug Metab Pharmacokinet. 2002;17(5):427-36. (PMID: 15618694)
Yuan L, Jia P, Sun Y, Zhao C, Zhi X, Sheng N, Zhang L: Study of in vitro metabolism of m-nisoldipine in human liver microsomes and recombinant cytochrome P450 enzymes by liquid chromatography-mass spectrometry. J Pharm Biomed Anal. 2014 Aug;97:65-71. doi: 10.1016/j.jpba.2014.03.030. Epub 2014 Mar 28. (PMID: 24816159)

>  <Comments>  (50) 


$$$$
CC02532
     RDKit          3D

 13 14  0  0  1  0  0  0  0  0999 V2000
   -1.9054    2.4225    0.5679 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6346    0.4277    0.0337 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7837    1.6557   -0.3925 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0141    0.3732   -0.8851 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6916   -0.4057   -0.7388 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.1816   -1.8521   -0.5352 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3418   -1.7443    0.4426 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8669   -0.3406    0.2112 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7483   -0.2109   -0.3024 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1254   -0.4250    1.0148 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7151    0.1829   -1.2078 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4527   -0.2396    1.3852 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3500    0.1562    0.4064 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  2  0
  2  3  1  0
  2  5  1  0
  2  8  1  0
  4 11  2  0
  4 13  1  0
  5  6  1  0
  5  9  1  1
  6  7  1  0
  7  8  1  0
  9 10  2  0
  9 11  1  0
 10 12  1  0
 12 13  2  0
M  END
>  <Name>  (51) 
N-Nitrosonornicotine1

>  <InChIKey>  (51) 
XKABJYQDMJTNGQ-SECBINFHSA-N

>  <PubChem_CID>  (51) 
12087452

>  <CYP1A2>  (51) 


>  <CYP2A6>  (51) 
<8,2;Cleavage;R1>
<8,H;Oxidation;R1>
<5,2;Cleavage;R1>

>  <CYP2B6>  (51) 


>  <CYP2C8>  (51) 


>  <CYP2C9>  (51) 


>  <CYP2C19>  (51) 


>  <CYP2D6>  (51) 


>  <CYP2E1>  (51) 


>  <CYP3A4>  (51) 


>  <References>  (51) 
Smith TJ, Liao A, Wang LD, Yang GY, Starcic S, Philbert MA, Yang CS: Characterization of xenobiotic-metabolizing enzymes and nitrosamine metabolism in the human esophagus. Carcinogenesis. 1998 Apr;19(4):667-72. doi: 10.1093/carcin/19.4.667. (PMID: 9600353)

>  <Comments>  (51) 


$$$$
CC02533
     RDKit          3D

 19 20  0  0  0  0  0  0  0  0999 V2000
   -0.4399    0.6436    1.1208 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7250   -1.5765    0.3778 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4972   -0.9514   -0.1935 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6418   -0.1478    0.6790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1733   -0.2214    0.2304 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4335   -0.4566   -1.5683 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8771   -0.9387    0.2908 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2245    1.7145    0.5865 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5778   -1.8819    0.0908 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4844    2.6900   -0.1069 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0743   -1.6535   -1.1884 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6030    1.8177    0.7413 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3945   -2.4186    1.0809 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1928    3.7808   -0.6519 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4020   -1.9654   -1.4809 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2801    2.9087    0.1963 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7222   -2.7304    0.7882 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5750    3.8903   -0.5002 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2259   -2.5038   -0.4927 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  1  8  1  0
  2  5  1  0
  2  9  1  0
  3  4  1  0
  3  6  1  0
  3  7  1  0
  4  5  1  0
  8 10  2  0
  8 12  1  0
  9 11  2  0
  9 13  1  0
 10 14  1  0
 11 15  1  0
 12 16  2  0
 13 17  2  0
 14 18  2  0
 15 19  2  0
 16 18  1  0
 17 19  1  0
M  END
>  <Name>  (52) 
Medifoxamine

>  <InChIKey>  (52) 
QNMGHBMGNRQPNL-UHFFFAOYSA-N

>  <PubChem_CID>  (52) 
36109

>  <CYP1A2>  (52) 


>  <CYP2A6>  (52) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2B6>  (52) 


>  <CYP2C8>  (52) 


>  <CYP2C9>  (52) 


>  <CYP2C19>  (52) 


>  <CYP2D6>  (52) 


>  <CYP2E1>  (52) 


>  <CYP3A4>  (52) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <References>  (52) 
Rendic S: Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448. doi: 10.1081/DMR-120001392. (PMID: 11996015)

>  <Comments>  (52) 


$$$$
CC02534
     RDKit          2D

 50 53  0  0  1  0  0  0  0  0999 V2000
   10.4027    0.0393    0.0000 S   0  0  0  0  0  0  0  0  0  1  0  0
    7.4051   -1.1082    0.0000 S   0  0  0  0  0  0  0  0  0  2  0  0
    2.3645    0.2063    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
    5.2224    0.2063    0.0000 O   0  0  0  0  0  0  0  0  0  4  0  0
    5.2224   -1.4438    0.0000 O   0  0  0  0  0  0  0  0  0  5  0  0
    4.5080   -0.2063    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
    7.3659    2.2688    0.0000 O   0  0  0  0  0  0  0  0  0  7  0  0
    4.5080    1.4438    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
    3.7935   -1.4438    0.0000 N   0  0  0  0  0  0  0  0  0  9  0  0
    6.6515    1.0313    0.0000 N   0  0  0  0  0  0  0  0  0 10  0  0
    8.0804    1.0313    0.0000 N   0  0  0  0  0  0  0  0  0 11  0  0
   10.2631    1.3668    0.0000 N   0  0  0  0  0  0  0  0  0 12  0  0
    7.5446   -2.4358    0.0000 N   0  0  0  0  0  0  0  0  0 13  0  0
    3.7935    1.0313    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    3.7935    0.2063    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    3.0790   -0.2063    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    3.0790   -1.0313    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    3.0790    1.4438    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    2.3645   -1.4438    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    5.9370    1.4438    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    5.9370    2.2688    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    5.2224    1.0313    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    3.0790    2.2688    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    2.3645   -2.2688    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
    6.6515    2.6813    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    5.2224    2.6813    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
    2.3645    2.6813    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
    3.7935    2.6813    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
    4.5080   -1.0313    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
    3.0790   -2.6813    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
    1.6500   -2.6813    0.0000 C   0  0  0  0  0  0  0  0  0 31  0  0
    7.3659    1.4438    0.0000 C   0  0  0  0  0  0  0  0  0 32  0  0
    2.3645    3.5063    0.0000 C   0  0  0  0  0  0  0  0  0 33  0  0
    3.7935    3.5063    0.0000 C   0  0  0  0  0  0  0  0  0 34  0  0
    3.0790   -3.5063    0.0000 C   0  0  0  0  0  0  0  0  0 35  0  0
    1.6500   -3.5063    0.0000 C   0  0  0  0  0  0  0  0  0 36  0  0
    3.0790    3.9188    0.0000 C   0  0  0  0  0  0  0  0  0 37  0  0
    2.3645   -3.9188    0.0000 C   0  0  0  0  0  0  0  0  0 38  0  0
    8.7949    1.4438    0.0000 C   0  0  0  0  0  0  0  0  0 39  0  0
    8.0804    0.2063    0.0000 C   0  0  0  0  0  0  0  0  0 40  0  0
    5.9370   -1.0313    0.0000 C   0  0  0  0  0  0  0  0  0 41  0  0
    9.5094    1.0313    0.0000 C   0  0  0  0  0  0  0  0  0 42  0  0
    6.6515   -1.4438    0.0000 C   0  0  0  0  0  0  0  0  0 43  0  0
   10.8152    0.7537    0.0000 C   0  0  0  0  0  0  0  0  0 44  0  0
    9.5956    0.2108    0.0000 C   0  0  0  0  0  0  0  0  0 45  0  0
   11.6356    0.8400    0.0000 C   0  0  0  0  0  0  0  0  0 46  0  0
   12.1206    0.1725    0.0000 C   0  0  0  0  0  0  0  0  0 47  0  0
   11.9712    1.5937    0.0000 C   0  0  0  0  0  0  0  0  0 48  0  0
    6.7377   -2.2643    0.0000 C   0  0  0  0  0  0  0  0  0 49  0  0
    7.9571   -1.7213    0.0000 C   0  0  0  0  0  0  0  0  0 50  0  0
  1 44  1  0
  1 45  1  0
  2 43  1  0
  2 50  1  0
 16  3  1  1
  4 22  2  0
  5 29  1  0
  5 41  1  0
  6 29  2  0
  7 32  2  0
 14  8  1  0
  8 22  1  0
 17  9  1  0
  9 29  1  0
 20 10  1  6
 10 32  1  0
 11 32  1  0
 11 39  1  0
 11 40  1  0
 12 42  1  0
 12 44  2  0
 13 49  1  0
 13 50  2  0
 14 15  1  6
 14 18  1  0
 15 16  1  0
 16 17  1  0
 17 19  1  1
 18 23  1  0
 19 24  1  0
 20 21  1  0
 20 22  1  0
 21 25  1  0
 21 26  1  0
 23 27  2  0
 23 28  1  0
 24 30  2  0
 24 31  1  0
 27 33  1  0
 28 34  2  0
 30 35  1  0
 31 36  2  0
 33 37  2  0
 34 37  1  0
 35 38  2  0
 36 38  1  0
 39 42  1  0
 41 43  1  0
 42 45  2  0
 43 49  2  0
 44 46  1  0
 46 47  1  0
 46 48  1  0
M  END
>  <Name>  (53) 
Ritonavir

>  <InChIKey>  (53) 
NCDNCNXCDXHOMX-XGKFQTDJSA-N

>  <PubChem_CID>  (53) 
392622

>  <CYP1A2>  (53) 


>  <CYP2A6>  (53) 


>  <CYP2B6>  (53) 


>  <CYP2C8>  (53) 


>  <CYP2C9>  (53) 


>  <CYP2C19>  (53) 


>  <CYP2D6>  (53) 
<49,9;Cleavage;R1>
<49,H;Oxidation;R1>
<3,H;Hydroxylation;R2>

>  <CYP2E1>  (53) 


>  <CYP3A4>  (53) 
<49,9;Cleavage;R1>
<49,H;Oxidation;R1>
<25,26;Cleavage;R2>
<23,H;Hydroxylation;R3>
<39,11;Cleavage;R4>

>  <References>  (53) 
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)
Rendic S: Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448. doi: 10.1081/DMR-120001392. (PMID: 11996015)

>  <Comments>  (53) 


$$$$
CC02536
     RDKit          3D

 25 26  0  0  1  0  0  0  0  0999 V2000
   -2.8151    3.3368    0.9059 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8156   -3.3889    0.5834 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2576   -2.8257    1.6873 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2315   -0.8373   -2.9284 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5285    2.3873   -0.3861 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8740   -2.0869   -0.9507 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8773    2.9144   -0.1591 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.9019    2.0496   -0.9159 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4502    3.1363    0.3842 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8637    2.5902    0.1485 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.9033    4.3769   -0.6037 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8784    0.5942   -0.5143 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9713    1.1369    0.5551 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3713    0.2002   -0.3822 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0464   -0.2830   -1.1911 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6899    0.1629    0.5226 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6666    0.7753    1.8560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4699   -1.1396   -0.0069 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7649   -0.5646    2.2312 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0251   -1.6276   -0.8209 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6688   -1.1819    0.8927 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1667   -1.5220    1.2998 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8363   -2.0772    0.2209 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2104   -1.8761   -2.2834 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9417   -4.2501   -0.1448 C   0  0  0  0  0  0  0  0  0  0  0  0
 10  1  1  1
  2 23  1  0
  2 25  1  0
  3 22  1  0
  4 24  2  0
  5  7  1  0
  5  9  1  0
  6 18  1  0
  6 24  1  0
  7  8  1  0
  7 11  1  6
  8 12  1  0
  9 10  1  0
 10 13  1  0
 12 15  2  0
 12 16  1  0
 13 14  2  0
 13 17  1  0
 14 18  1  0
 15 20  1  0
 16 21  2  0
 17 19  2  0
 18 22  2  0
 19 22  1  0
 20 23  2  0
 21 23  1  0
M  END
>  <Name>  (54) 
Formoterol

>  <InChIKey>  (54) 
BPZSYCZIITTYBL-YJYMSZOUSA-N

>  <PubChem_CID>  (54) 
3083544

>  <CYP1A2>  (54) 


>  <CYP2A6>  (54) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2B6>  (54) 


>  <CYP2C8>  (54) 


>  <CYP2C9>  (54) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2C19>  (54) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2D6>  (54) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2E1>  (54) 


>  <CYP3A4>  (54) 


>  <References>  (54) 
Walsh P (2003). Physicians' Desk Reference (57th ed., pp. 2275). Medical Economics. (ISBN: 9781563634451)

>  <Comments>  (54) 


$$$$
CC02537
     RDKit          3D

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0488    2.1750   -0.1529 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5991    2.3578    1.0251 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1817    4.2817    0.0652 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9267   -2.4767    0.5053 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8144   -2.6423    0.5551 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0037    0.7872   -0.7151 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2897    0.0797   -0.4508 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2989    0.0185   -0.4316 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8452   -0.7463   -1.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3901    0.2736   -1.2228 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9366    0.2435    0.7741 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3083   -0.8858    0.6000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4151    3.2701   -0.7383 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0478   -1.4084   -1.1804 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5708   -0.4229   -0.9653 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1391   -0.4188    1.0216 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4891   -1.5821    0.8576 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6946   -1.2447    0.0444 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6203   -1.3506    0.0749 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4354    3.6787    1.1236 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9257   -1.9243    0.2986 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8305   -2.0630    0.3397 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  1 13  1  0
  2 20  2  0
  3 13  2  0
  3 20  1  0
  4 21  3  0
  5 22  3  0
  6  7  1  0
  6  8  1  0
  7  9  2  0
  7 11  1  0
  8 10  2  0
  8 12  1  0
  9 14  1  0
 10 15  1  0
 11 16  2  0
 12 17  2  0
 14 18  2  0
 15 19  2  0
 16 18  1  0
 17 19  1  0
 18 21  1  0
 19 22  1  0
M  END
>  <Name>  (55) 
Letrozole

>  <InChIKey>  (55) 
HPJKCIUCZWXJDR-UHFFFAOYSA-N

>  <PubChem_CID>  (55) 
3902

>  <CYP1A2>  (55) 


>  <CYP2A6>  (55) 
<7,16;Cleavage;R1>
<16,H;Oxidation;R1>

>  <CYP2B6>  (55) 


>  <CYP2C8>  (55) 


>  <CYP2C9>  (55) 


>  <CYP2C19>  (55) 


>  <CYP2D6>  (55) 


>  <CYP2E1>  (55) 


>  <CYP3A4>  (55) 
<7,16;Cleavage;R1>
<16,H;Oxidation;R1>

>  <References>  (55) 
Jeong S, Woo MM, Flockhart DA, Desta Z: Inhibition of drug metabolizing cytochrome P450s by the aromatase inhibitor drug letrozole and its major oxidative metabolite 4,4'-methanol-bisbenzonitrile in vitro. Cancer Chemother Pharmacol. 2009 Oct;64(5):867-75. doi: 10.1007/s00280-009-0935-7. Epub 2009 Feb 7. (PMID: 19198839)
Desta Z, Ward BA, Flockhart DA: In vitro letrozole N-dealkylation is mainly catalyzed by human cytochrome P450 (CYP) 3A Clin Pharmacol Ther. 2005 Feb 01;77(2):79. doi: 10.1016/j.clpt.2004.12.193.

>  <Comments>  (55) 


$$$$
CC02538
     RDKit          3D

  8  7  0  0  0  0  0  0  0  0999 V2000
    1.5212   -1.8146   -0.0615 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.3480    0.9725   -0.0168 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.2812    0.3042   -1.3497 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5778    1.4731    0.4770 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2707   -0.6731    0.4434 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2689    0.2391    0.0038 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0991   -0.1813    0.5146 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5696   -0.3199   -0.0109 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  7  1  0
  2  7  1  0
  3  6  1  0
  4  6  1  0
  5  6  1  0
  5  8  1  0
  6  7  1  0
M  END
>  <Name>  (56) 
Methoxyflurane

>  <InChIKey>  (56) 
RFKMCNOHBTXSMU-UHFFFAOYSA-N

>  <PubChem_CID>  (56) 
4116

>  <CYP1A2>  (56) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2A6>  (56) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2B6>  (56) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2C8>  (56) 


>  <CYP2C9>  (56) 


>  <CYP2C19>  (56) 


>  <CYP2D6>  (56) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2E1>  (56) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP3A4>  (56) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <References>  (56) 
Kharasch ED, Hankins DC, Thummel KE: Human kidney methoxyflurane and sevoflurane metabolism. Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity. Anesthesiology. 1995 Mar;82(3):689-99. doi: 10.1097/00000542-199503000-00011. (PMID: 7879937)
Chang GW, Kam PC: The physiological and pharmacological roles of cytochrome P450 isoenzymes. Anaesthesia. 1999 Jan;54(1):42-50. doi: 10.1046/j.1365-2044.1999.00602.x. (PMID: 10209369)
Nelson SD, Trager WF: The use of deuterium isotope effects to probe the active site properties, mechanism of cytochrome P450-catalyzed reactions, and mechanisms of metabolically dependent toxicity. Drug Metab Dispos. 2003 Dec;31(12):1481-98. doi: 10.1124/dmd.31.12.1481. (PMID: 14625345)

>  <Comments>  (56) 
One paper says CYP1A2 and CYP2D6 don't catalyze the metabolism of methoxyflurane but one experiment in the other paper shows that those two enzymes have no activity. The pathway of defluorination used is shown in the third reference.

$$$$
CC02539
     RDKit          3D

 12 11  0  0  0  0  0  0  0  0999 V2000
    1.2852   -1.7729   -0.3891 F   0  0  0  0  0  0  0  0  0  1  0  0
    0.0143   -1.3472    1.3282 F   0  0  0  0  0  0  0  0  0  2  0  0
   -0.8714   -2.0796   -0.5270 F   0  0  0  0  0  0  0  0  0  3  0  0
   -2.4368    0.0880   -0.5846 F   0  0  0  0  0  0  0  0  0  4  0  0
   -1.5027    2.0543   -0.4320 F   0  0  0  0  0  0  0  0  0  5  0  0
   -1.5295    0.7172    1.2925 F   0  0  0  0  0  0  0  0  0  6  0  0
    3.2025    1.2778    0.1765 F   0  0  0  0  0  0  0  0  0  7  0  0
    0.9768    0.9476    0.0483 O   0  0  0  0  0  0  0  0  0  8  0  0
   -0.0791    0.1569   -0.4888 C   0  0  1  0  0  0  0  0  0  9  0  0
    0.0855   -1.2739   -0.0197 C   0  0  2  0  0  0  0  0  0 10  0  0
   -1.3951    0.7639   -0.0508 C   0  0  1  0  0  0  0  0  0 11  0  0
    2.2503    0.4680   -0.3535 C   0  0  0  0  0  0  0  0  0 12  0  0
 10  1  1  6
  2 10  1  0
  3 10  1  0
 11  4  1  6
  5 11  1  0
  6 11  1  0
  7 12  1  0
  9  8  1  1
  8 12  1  0
  9 10  1  0
  9 11  1  0
M  END
>  <Name>  (57) 
Sevoflurane

>  <InChIKey>  (57) 
DFEYYRMXOJXZRJ-UHFFFAOYSA-N

>  <PubChem_CID>  (57) 
5206

>  <CYP1A2>  (57) 


>  <CYP2A6>  (57) 
<6,7;Cleavage;R1>
<7,H;Oxidation;R1>

>  <CYP2B6>  (57) 
<6,7;Cleavage;R1>
<7,H;Oxidation;R1>

>  <CYP2C8>  (57) 


>  <CYP2C9>  (57) 


>  <CYP2C19>  (57) 


>  <CYP2D6>  (57) 


>  <CYP2E1>  (57) 
<6,7;Cleavage;R1>
<7,H;Oxidation;R1>

>  <CYP3A4>  (57) 
<6,7;Cleavage;R1>
<7,H;Oxidation;R1>

>  <References>  (57) 
Kharasch ED, Hankins DC, Thummel KE: Human kidney methoxyflurane and sevoflurane metabolism. Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity. Anesthesiology. 1995 Mar;82(3):689-99. doi: 10.1097/00000542-199503000-00011. (PMID: 7879937)
Chang GW, Kam PC: The physiological and pharmacological roles of cytochrome P450 isoenzymes. Anaesthesia. 1999 Jan;54(1):42-50. doi: 10.1046/j.1365-2044.1999.00602.x. (PMID: 10209369)

>  <Comments>  (57) 


$$$$
CC02540
     RDKit          2D

 51 55  0  0  1  0  0  0  0  0999 V2000
    1.6500    1.2766    0.0000 Cl  0  0  0  0  0  0  0  0  0  1  0  0
   10.3495   -0.5410    0.0000 S   0  0  0  0  0  0  0  0  0  2  0  0
    8.7086   -0.7136    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
   11.0170   -0.0561    0.0000 O   0  0  0  0  0  0  0  0  0  4  0  0
    9.6821   -1.0260    0.0000 O   0  0  0  0  0  0  0  0  0  5  0  0
    7.8880   -0.7998    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
    4.5624    0.4715    0.0000 O   0  0  0  0  0  0  0  0  0  7  0  0
    7.3262   -1.7730    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
    3.8949   -2.8492    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
    5.0509   -3.6890    0.0000 O   0  0  0  0  0  0  0  0  0 10  0  0
    4.5624    3.7715    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
    7.7387    0.6214    0.0000 N   0  0  0  0  0  0  0  0  0 12  0  0
    9.8646    0.1264    0.0000 N   0  0  0  0  0  0  0  0  0 13  0  0
    6.1701   -0.9330    0.0000 N   0  0  0  0  0  0  0  0  0 14  0  0
    5.2003   -2.2680    0.0000 N   0  0  0  0  0  0  0  0  0 15  0  0
    5.2769    1.7090    0.0000 N   0  0  0  0  0  0  0  0  0 16  0  0
    8.5592    0.7076    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    8.4730    1.5281    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    9.2266    1.1926    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    9.0441    0.0402    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   10.8345   -1.2085    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    7.9880    2.1955    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   11.5881   -1.5441    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   10.9207   -2.0290    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
    6.5826   -0.2185    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    7.4032   -0.1323    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
    6.0306    0.3945    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
    5.2769    0.0590    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
    5.3632   -0.7615    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
    8.3235    2.9493    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
    6.5057   -1.6867    0.0000 C   0  0  0  0  0  0  0  0  0 31  0  0
    6.0208   -2.3542    0.0000 C   0  0  0  0  0  0  0  0  0 32  0  0
    6.3563   -3.1078    0.0000 C   0  0  0  0  0  0  0  0  0 33  0  0
    6.6918   -3.8616    0.0000 C   0  0  0  0  0  0  0  0  0 34  0  0
    5.6027   -3.4434    0.0000 C   0  0  0  0  0  0  0  0  0 35  0  0
    7.1100   -2.7723    0.0000 C   0  0  0  0  0  0  0  0  0 36  0  0
    4.5624    1.2965    0.0000 C   0  0  0  0  0  0  0  0  0 37  0  0
    4.7154   -2.9354    0.0000 C   0  0  0  0  0  0  0  0  0 38  0  0
    3.8479    1.7090    0.0000 C   0  0  0  0  0  0  0  0  0 39  0  0
    3.8479    2.5340    0.0000 C   0  0  0  0  0  0  0  0  0 40  0  0
    3.1105    1.2679    0.0000 C   0  0  0  0  0  0  0  0  0 41  0  0
    5.2769    2.5340    0.0000 C   0  0  0  0  0  0  0  0  0 42  0  0
    4.5624    2.9465    0.0000 C   0  0  0  0  0  0  0  0  0 43  0  0
    3.4099   -3.5166    0.0000 C   0  0  0  0  0  0  0  0  0 44  0  0
    3.1105    2.9752    0.0000 C   0  0  0  0  0  0  0  0  0 45  0  0
    2.3629    1.6919    0.0000 C   0  0  0  0  0  0  0  0  0 46  0  0
    2.3629    2.5512    0.0000 C   0  0  0  0  0  0  0  0  0 47  0  0
    2.9250   -4.1840    0.0000 C   0  0  0  0  0  0  0  0  0 48  0  0
    2.7425   -3.0317    0.0000 C   0  0  0  0  0  0  0  0  0 49  0  0
    4.0774   -4.0016    0.0000 C   0  0  0  0  0  0  0  0  0 50  0  0
    5.2769    4.1840    0.0000 C   0  0  0  0  0  0  0  0  0 51  0  0
  1 46  1  0
  2  4  2  0
  2  5  2  0
  2 13  1  0
  2 21  1  0
  3 20  2  0
  6 26  2  0
 28  7  1  6
  7 37  1  0
  8 31  2  0
  9 38  1  0
  9 44  1  0
 10 38  2  0
 11 43  1  0
 11 51  1  0
 17 12  1  1
 12 26  1  0
 13 20  1  0
 14 25  1  0
 14 29  1  0
 14 31  1  0
 32 15  1  6
 15 38  1  0
 16 37  2  0
 16 42  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
 18 19  1  0
 18 22  1  6
 21 23  1  0
 21 24  1  0
 22 30  2  0
 23 24  1  0
 25 26  1  1
 25 27  1  0
 27 28  1  0
 28 29  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 33 35  1  0
 33 36  1  0
 37 39  1  0
 39 40  2  0
 39 41  1  0
 40 43  1  0
 40 45  1  0
 41 46  2  0
 42 43  2  0
 44 48  1  0
 44 49  1  0
 44 50  1  0
 45 47  2  0
 46 47  1  0
M  END
>  <Name>  (58) 
Asunaprevir

>  <InChIKey>  (58) 
XRWSZZJLZRKHHD-WVWIJVSJSA-N

>  <PubChem_CID>  (58) 
16076883

>  <CYP1A2>  (58) 


>  <CYP2A6>  (58) 


>  <CYP2B6>  (58) 


>  <CYP2C8>  (58) 


>  <CYP2C9>  (58) 


>  <CYP2C19>  (58) 


>  <CYP2D6>  (58) 


>  <CYP2E1>  (58) 


>  <CYP3A4>  (58) 
<47,48;Cleavage;R1>
<48,H;Oxidation;R1>

>  <References>  (58) 
Gong J, Eley T, He B, Arora V, Philip T, Jiang H, Easter J, Humphreys WG, Iyer RA, Li W: Characterization of ADME properties of [(14)C]asunaprevir (BMS-650032) in humans. Xenobiotica. 2016;46(1):52-64. doi: 10.3109/00498254.2015.1048487. Epub 2015 Jul  7. (PMID: 26153443)

>  <Comments>  (58) 


$$$$
CC02541
     RDKit          3D

 23 24  0  0  1  0  0  0  0  0999 V2000
    0.3779    1.9156    0.2123 S   0  0  1  0  0  0  0  0  0  1  0  0
   -2.4299    1.2981   -0.5663 S   0  0  0  0  0  0  0  0  0  2  0  0
   -4.8382   -0.3542   -0.7189 S   0  0  2  0  0  0  0  0  0  3  0  0
    0.0031    2.9006    1.2068 O   0  0  0  0  0  0  0  0  0  4  0  0
    0.6748    2.2729   -1.1591 O   0  0  0  0  0  0  0  0  0  5  0  0
    4.9963    0.2262   -1.6965 O   0  0  0  0  0  0  0  0  0  6  0  0
   -4.9839    0.5548   -1.8501 O   0  0  0  0  0  0  0  0  0  7  0  0
   -5.0573   -1.7855   -0.8849 O   0  0  0  0  0  0  0  0  0  8  0  0
    1.6264    0.8905    0.8366 N   0  0  0  0  0  0  0  0  0  9  0  0
    0.8178   -1.9944    0.4003 N   0  0  0  0  0  0  0  0  0 10  0  0
   -5.8634    0.2080    0.5397 N   0  0  0  0  0  0  0  0  0 11  0  0
    0.1690   -1.0986    1.3614 C   0  0  1  0  0  0  0  0  0 12  0  0
    1.1831   -0.0653    1.9140 C   0  0  0  0  0  0  0  0  0 13  0  0
   -1.0195   -0.4696    0.6789 C   0  0  0  0  0  0  0  0  0 14  0  0
   -0.9828    0.8035    0.1521 C   0  0  0  0  0  0  0  0  0 15  0  0
    2.9153    1.5523    1.1476 C   0  0  0  0  0  0  0  0  0 16  0  0
   -2.3080   -1.0543    0.4741 C   0  0  0  0  0  0  0  0  0 17  0  0
    3.8244    1.5418   -0.0736 C   0  0  0  0  0  0  0  0  0 18  0  0
   -3.1679   -0.2049   -0.1928 C   0  0  0  0  0  0  0  0  0 19  0  0
    1.9832   -2.6285    0.9953 C   0  0  0  0  0  0  0  0  0 20  0  0
    4.1325    0.1345   -0.5713 C   0  0  0  0  0  0  0  0  0 21  0  0
    2.6451   -3.5866    0.0196 C   0  0  0  0  0  0  0  0  0 22  0  0
    5.3020   -1.0570   -2.2251 C   0  0  0  0  0  0  0  0  0 23  0  0
  1  4  2  0
  1  5  2  0
  1  9  1  1
  1 15  1  0
  2 15  1  0
  2 19  1  0
  3  7  2  0
  3  8  2  0
  3 11  1  1
  3 19  1  0
  6 21  1  0
  6 23  1  0
  9 13  1  0
  9 16  1  0
 12 10  1  6
 10 20  1  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 14 17  1  0
 16 18  1  0
 17 19  2  0
 18 21  1  0
 20 22  1  0
M  END
>  <Name>  (59) 
Brinzolamide

>  <InChIKey>  (59) 
HCRKCZRJWPKOAR-JTQLQIEISA-N

>  <PubChem_CID>  (59) 
68844

>  <CYP1A2>  (59) 


>  <CYP2A6>  (59) 


>  <CYP2B6>  (59) 


>  <CYP2C8>  (59) 


>  <CYP2C9>  (59) 


>  <CYP2C19>  (59) 


>  <CYP2D6>  (59) 


>  <CYP2E1>  (59) 


>  <CYP3A4>  (59) 
<12,13;Cleavage;R1>
<13,H;Oxidation;R1>
<4,5;Cleavage;R2>
<5,H;Oxidation;R2>

>  <References>  (59) 
Rendic S: Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448. doi: 10.1081/DMR-120001392. (PMID: 11996015)

>  <Comments>  (59) 


$$$$
CC02542
     RDKit          3D

 19 20  0  0  1  0  0  0  0  0999 V2000
   -2.5851   -2.8603   -0.7778 O   0  0  0  0  0  0  0  0  0  1  0  0
    1.0285   -0.0521    0.6669 N   0  0  0  0  0  0  0  0  0  2  0  0
    5.4330    1.4442   -1.7003 N   0  0  0  0  0  0  0  0  0  3  0  0
   -0.6563    2.1552    0.5203 N   0  0  0  0  0  0  0  0  0  4  0  0
    1.9458   -1.1688    0.7589 C   0  0  1  0  0  0  0  0  0  5  0  0
    3.3965   -0.6686    0.7311 C   0  0  0  0  0  0  0  0  0  6  0  0
    3.7125    0.1505   -0.5265 C   0  0  0  0  0  0  0  0  0  7  0  0
    1.6566   -1.9312    2.0478 C   0  0  0  0  0  0  0  0  0  8  0  0
   -0.2918   -0.1773    0.2736 C   0  0  0  0  0  0  0  0  0  9  0  0
    5.1435    0.6856   -0.4890 C   0  0  0  0  0  0  0  0  0 10  0  0
   -1.1455    0.9423    0.2000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -0.7991   -1.4537   -0.0613 C   0  0  0  0  0  0  0  0  0 12  0  0
   -2.4847    0.7633   -0.2056 C   0  0  0  0  0  0  0  0  0 13  0  0
   -2.1192   -1.6228   -0.4600 C   0  0  0  0  0  0  0  0  0 14  0  0
   -2.9620   -0.5173   -0.5326 C   0  0  0  0  0  0  0  0  0 15  0  0
   -3.3113    1.8931   -0.2698 C   0  0  0  0  0  0  0  0  0 16  0  0
   -2.8100    3.1442    0.0596 C   0  0  0  0  0  0  0  0  0 17  0  0
   -1.4870    3.2201    0.4452 C   0  0  0  0  0  0  0  0  0 18  0  0
   -1.6646   -3.9466   -0.6804 C   0  0  0  0  0  0  0  0  0 19  0  0
  1 14  1  0
  1 19  1  0
  2  5  1  0
  2  9  1  0
  3 10  1  0
  4 11  2  0
  4 18  1  0
  5  6  1  0
  5  8  1  1
  6  7  1  0
  7 10  1  0
  9 11  1  0
  9 12  2  0
 11 13  1  0
 12 14  1  0
 13 15  1  0
 13 16  2  0
 14 15  2  0
 16 17  1  0
 17 18  2  0
M  END
>  <Name>  (60) 
Primaquine

>  <InChIKey>  (60) 
INDBQLZJXZLFIT-LLVKDONJSA-N

>  <PubChem_CID>  (60) 
3044368

>  <CYP1A2>  (60) 


>  <CYP2A6>  (60) 


>  <CYP2B6>  (60) 


>  <CYP2C8>  (60) 


>  <CYP2C9>  (60) 


>  <CYP2C19>  (60) 


>  <CYP2D6>  (60) 


>  <CYP2E1>  (60) 


>  <CYP3A4>  (60) 
<9,10;Cleavage;R1>
<9,H;Oxidation;R1>

>  <References>  (60) 
Rendic S: Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448. doi: 10.1081/DMR-120001392. (PMID: 11996015)

>  <Comments>  (60) 
It should also be a substrate for CYP2D6 and it was reported as a substrate for CYP2A6 in some other paper. The corresponding metabolites/metabolic pathways cannot be identified.

$$$$
CC02543
     RDKit          3D

 13 13  0  0  1  0  0  0  0  0999 V2000
    2.2430    0.1867   -0.3554 N   0  0  0  0  0  0  0  0  0  1  0  0
    0.8905   -0.0017    0.1776 C   0  0  1  0  0  0  0  0  0  2  0  0
   -0.1436    0.3370   -0.9116 C   0  0  0  0  0  0  0  0  0  3  0  0
   -1.5747    0.2121   -0.4464 C   0  0  0  0  0  0  0  0  0  4  0  0
    0.7661   -1.4418    0.6759 C   0  0  0  0  0  0  0  0  0  5  0  0
   -2.2306   -1.0006   -0.5858 C   0  0  0  0  0  0  0  0  0  6  0  0
   -2.2060    1.3125    0.1108 C   0  0  0  0  0  0  0  0  0  7  0  0
    3.2380   -0.0670    0.6731 C   0  0  0  0  0  0  0  0  0  8  0  0
   -3.5529   -1.1160   -0.1566 C   0  0  0  0  0  0  0  0  0  9  0  0
   -3.5282    1.1973    0.5403 C   0  0  0  0  0  0  0  0  0 10  0  0
   -4.2016   -0.0170    0.4064 C   0  0  0  0  0  0  0  0  0 11  0  0
    4.5939    0.1224    0.1482 C   0  0  0  0  0  0  0  0  0 12  0  0
    5.7063    0.2762   -0.2765 C   0  0  0  0  0  0  0  0  0 13  0  0
  1  2  1  0
  1  8  1  0
  2  3  1  0
  2  5  1  6
  3  4  1  0
  4  6  2  0
  4  7  1  0
  6  9  1  0
  7 10  2  0
  8 12  1  0
  9 11  2  0
 10 11  1  0
 12 13  3  0
M  END
>  <Name>  (61) 
Desmethylselegiline

>  <InChIKey>  (61) 
UUFAJPMQSFXDFR-LLVKDONJSA-N

>  <PubChem_CID>  (61) 
185859

>  <CYP1A2>  (61) 


>  <CYP2A6>  (61) 
<11,1;Cleavage;R1>
<11,H;Oxidation;R1>

>  <CYP2B6>  (61) 
<11,1;Cleavage;R1>
<11,H;Oxidation;R1>

>  <CYP2C8>  (61) 


>  <CYP2C9>  (61) 


>  <CYP2C19>  (61) 


>  <CYP2D6>  (61) 


>  <CYP2E1>  (61) 


>  <CYP3A4>  (61) 
<11,1;Cleavage;R1>
<11,H;Oxidation;R1>

>  <References>  (61) 
Rendic S: Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448. doi: 10.1081/DMR-120001392. (PMID: 11996015)

>  <Comments>  (61) 


$$$$
CC02544
     RDKit          3D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -1.4225    0.4419   -0.0150 N   0  0  0  0  0  0  0  0  0  1  0  0
    1.1797    1.6949    0.1163 N   0  0  0  0  0  0  0  0  0  2  0  0
   -0.2433   -0.2971    0.4526 C   0  0  0  0  0  0  0  0  0  3  0  0
   -1.2798    1.8730    0.2794 C   0  0  0  0  0  0  0  0  0  4  0  0
   -2.6423   -0.0928    0.5866 C   0  0  1  0  0  0  0  0  0  5  0  0
    1.0365    0.2636   -0.1772 C   0  0  0  0  0  0  0  0  0  6  0  0
    0.0001    2.4345   -0.3493 C   0  0  0  0  0  0  0  0  0  7  0  0
    2.3990    2.2291   -0.4873 C   0  0  0  0  0  0  0  0  0  8  0  0
   -3.8653    0.7541    0.2669 C   0  0  0  0  0  0  0  0  0  9  0  0
   -2.8635   -1.5588    0.2445 C   0  0  0  0  0  0  0  0  0 10  0  0
    3.6212    1.5316    0.0322 C   0  0  0  0  0  0  0  0  0 11  0  0
   -4.2025    1.7873    1.1176 C   0  0  0  0  0  0  0  0  0 12  0  0
   -3.5300   -2.3616    1.1480 C   0  0  0  0  0  0  0  0  0 13  0  0
   -4.6008    0.4645   -0.8644 C   0  0  0  0  0  0  0  0  0 14  0  0
   -2.3915   -2.0420   -0.9589 C   0  0  0  0  0  0  0  0  0 15  0  0
   -5.3235    2.5641    0.8246 C   0  0  0  0  0  0  0  0  0 16  0  0
   -3.7329   -3.7056    0.8346 C   0  0  0  0  0  0  0  0  0 17  0  0
   -5.7218    1.2412   -1.1574 C   0  0  0  0  0  0  0  0  0 18  0  0
   -2.5945   -3.3860   -1.2724 C   0  0  0  0  0  0  0  0  0 19  0  0
    4.4798    0.8653   -0.7560 C   0  0  0  0  0  0  0  0  0 20  0  0
   -6.0829    2.2910   -0.3129 C   0  0  0  0  0  0  0  0  0 21  0  0
   -3.2654   -4.2177   -0.3756 C   0  0  0  0  0  0  0  0  0 22  0  0
    5.6986    0.1799   -0.2950 C   0  0  0  0  0  0  0  0  0 23  0  0
    5.8191   -0.1669    1.0415 C   0  0  0  0  0  0  0  0  0 24  0  0
    6.7033   -0.1061   -1.2060 C   0  0  0  0  0  0  0  0  0 25  0  0
    6.9739   -0.8159    1.4784 C   0  0  0  0  0  0  0  0  0 26  0  0
    7.8581   -0.7553   -0.7691 C   0  0  0  0  0  0  0  0  0 27  0  0
    7.9933   -1.1102    0.5732 C   0  0  0  0  0  0  0  0  0 28  0  0
  1  3  1  0
  1  4  1  0
  5  1  1  6
  2  6  1  0
  2  7  1  0
  2  8  1  0
  3  6  1  0
  4  7  1  0
  5  9  1  0
  5 10  1  0
  8 11  1  0
  9 12  2  0
  9 14  1  0
 10 13  2  0
 10 15  1  0
 11 20  2  0
 12 16  1  0
 13 17  1  0
 14 18  2  0
 15 19  2  0
 16 21  2  0
 17 22  2  0
 18 21  1  0
 19 22  1  0
 20 23  1  0
 23 24  2  0
 23 25  1  0
 24 26  1  0
 25 27  2  0
 26 28  2  0
 27 28  1  0
M  END
>  <Name>  (62) 
Cinnarizine

>  <InChIKey>  (62) 
DERZBLKQOCDDDZ-JLHYYAGUSA-N

>  <PubChem_CID>  (62) 
1547484

>  <CYP1A2>  (62) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2A6>  (62) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2B6>  (62) 
<6,H;Hydroxylation;R1>
<12,H;Hydroxylation;R2>

>  <CYP2C8>  (62) 


>  <CYP2C9>  (62) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2C19>  (62) 


>  <CYP2D6>  (62) 
<24,H;Hydroxylation;R1>

>  <CYP2E1>  (62) 


>  <CYP3A4>  (62) 


>  <References>  (62) 
Rendic S: Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448. doi: 10.1081/DMR-120001392. (PMID: 11996015)
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (62) 


$$$$
CC02545
     RDKit          3D

 30 33  0  0  0  0  0  0  0  0999 V2000
   -3.0735   -5.4571   -0.5171 F   0  0  0  0  0  0  0  0  0  1  0  0
   -6.8332    3.0606   -0.5322 F   0  0  0  0  0  0  0  0  0  2  0  0
   -1.0724    0.5166    0.0313 N   0  0  0  0  0  0  0  0  0  3  0  0
    1.5217    1.7903    0.1158 N   0  0  0  0  0  0  0  0  0  4  0  0
   -0.9373    1.9533    0.3014 C   0  0  0  0  0  0  0  0  0  5  0  0
    0.1169   -0.2063    0.4983 C   0  0  0  0  0  0  0  0  0  6  0  0
   -2.2821   -0.0171    0.6538 C   0  0  2  0  0  0  0  0  0  7  0  0
    0.3320    2.5139   -0.3493 C   0  0  0  0  0  0  0  0  0  8  0  0
    1.3860    0.3535   -0.1534 C   0  0  0  0  0  0  0  0  0  9  0  0
    2.7308    2.3235   -0.5087 C   0  0  0  0  0  0  0  0  0 10  0  0
   -2.4959   -1.4900    0.3374 C   0  0  0  0  0  0  0  0  0 11  0  0
   -3.5145    0.8157    0.3334 C   0  0  0  0  0  0  0  0  0 12  0  0
    3.9635    1.6434    0.0090 C   0  0  0  0  0  0  0  0  0 13  0  0
   -3.1472   -2.2831    1.2599 C   0  0  0  0  0  0  0  0  0 14  0  0
   -3.8506    1.8599    1.1706 C   0  0  0  0  0  0  0  0  0 15  0  0
   -2.0324   -1.9883   -0.8631 C   0  0  0  0  0  0  0  0  0 16  0  0
   -4.2588    0.5021   -0.7856 C   0  0  0  0  0  0  0  0  0 17  0  0
   -3.3435   -3.6332    0.9691 C   0  0  0  0  0  0  0  0  0 18  0  0
   -4.9802    2.6236    0.8762 C   0  0  0  0  0  0  0  0  0 19  0  0
   -2.2289   -3.3382   -1.1538 C   0  0  0  0  0  0  0  0  0 20  0  0
   -5.3881    1.2660   -1.0801 C   0  0  0  0  0  0  0  0  0 21  0  0
    4.8187    0.9712   -0.7778 C   0  0  0  0  0  0  0  0  0 22  0  0
   -2.8844   -4.1608   -0.2378 C   0  0  0  0  0  0  0  0  0 23  0  0
   -5.7489    2.3267   -0.2492 C   0  0  0  0  0  0  0  0  0 24  0  0
    6.0483    0.3027   -0.3203 C   0  0  0  0  0  0  0  0  0 25  0  0
    6.1868   -0.0218    1.0202 C   0  0  0  0  0  0  0  0  0 26  0  0
    7.0445    0.0096   -1.2382 C   0  0  0  0  0  0  0  0  0 27  0  0
    7.3513   -0.6556    1.4537 C   0  0  0  0  0  0  0  0  0 28  0  0
    8.2090   -0.6243   -0.8048 C   0  0  0  0  0  0  0  0  0 29  0  0
    8.3623   -0.9568    0.5412 C   0  0  0  0  0  0  0  0  0 30  0  0
  1 23  1  0
  2 24  1  0
  3  5  1  0
  3  6  1  0
  7  3  1  6
  4  8  1  0
  4  9  1  0
  4 10  1  0
  5  8  1  0
  6  9  1  0
  7 11  1  0
  7 12  1  0
 10 13  1  0
 11 14  2  0
 11 16  1  0
 12 15  2  0
 12 17  1  0
 13 22  2  0
 14 18  1  0
 15 19  1  0
 16 20  2  0
 17 21  2  0
 18 23  2  0
 19 24  2  0
 20 23  1  0
 21 24  1  0
 22 25  1  0
 25 26  2  0
 25 27  1  0
 26 28  1  0
 27 29  2  0
 28 30  2  0
 29 30  1  0
M  END
>  <Name>  (63) 
Flunarizine

>  <InChIKey>  (63) 
SMANXXCATUTDDT-QPJJXVBHSA-N

>  <PubChem_CID>  (63) 
941361

>  <CYP1A2>  (63) 
<6,7;Cleavage;R1>
<6,H;Oxidation;R1>
<10,11;Cleavage;R2>
<11,H;Oxidation;R2>

>  <CYP2A6>  (63) 
<6,7;Cleavage;R1>
<6,H;Oxidation;R1>
<10,11;Cleavage;R2>
<11,H;Oxidation;R2>

>  <CYP2B6>  (63) 


>  <CYP2C8>  (63) 


>  <CYP2C9>  (63) 
<6,7;Cleavage;R1>
<6,H;Oxidation;R1>
<10,11;Cleavage;R2>
<11,H;Oxidation;R2>

>  <CYP2C19>  (63) 


>  <CYP2D6>  (63) 
<17,H;Hydroxylation;R1>

>  <CYP2E1>  (63) 


>  <CYP3A4>  (63) 


>  <References>  (63) 
Rendic S: Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448. doi: 10.1081/DMR-120001392. (PMID: 11996015)
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (63) 


$$$$
CC02546
     RDKit          3D

 14 15  0  0  1  0  0  0  0  0999 V2000
   -2.8525   -0.9615   -0.3112 N   0  0  0  0  0  0  0  0  0  1  0  0
    2.6113   -0.0444    0.2736 N   0  0  0  0  0  0  0  0  0  2  0  0
    1.4124   -0.6418    0.3239 N   0  0  0  0  0  0  0  0  0  3  0  0
    1.3172    1.5862   -0.0690 N   0  0  0  0  0  0  0  0  0  4  0  0
    2.6030    1.2757    0.0425 N   0  0  0  0  0  0  0  0  0  5  0  0
   -3.6266    0.1630    0.2271 C   0  0  0  0  0  0  0  0  0  6  0  0
   -1.4663   -0.9253    0.1971 C   0  0  0  0  0  0  0  0  0  7  0  0
   -3.0353    1.4931   -0.2550 C   0  0  0  0  0  0  0  0  0  8  0  0
   -0.8018    0.4285    0.0380 C   0  0  0  0  0  0  0  0  0  9  0  0
   -1.5371    1.5321   -0.1877 C   0  0  0  0  0  0  0  0  0 10  0  0
   -3.4874   -2.2372    0.0167 C   0  0  0  0  0  0  0  0  0 11  0  0
    0.6376    0.4198    0.1040 C   0  0  0  0  0  0  0  0  0 12  0  0
    3.8371   -0.7775    0.4556 C   0  0  0  0  0  0  0  0  0 13  0  0
    4.3883   -1.3106   -0.8556 C   0  0  0  0  0  0  0  0  0 14  0  0
  1  6  1  0
  1  7  1  0
  1 11  1  0
  2  3  1  0
  2  5  1  0
  2 13  1  0
  3 12  2  0
  4  5  2  0
  4 12  1  0
  6  8  1  0
  7  9  1  0
  8 10  1  0
  9 10  2  0
  9 12  1  0
 13 14  1  0
M  END
>  <Name>  (64) 
Alvameline

>  <InChIKey>  (64) 
RNMOMKCRCIRYCZ-UHFFFAOYSA-N

>  <PubChem_CID>  (64) 
178030

>  <CYP1A2>  (64) 
<1,2;Cleavage;R1>
<2,H;Oxidation;R1>
<1,N;N-Oxidation;R2>

>  <CYP2A6>  (64) 
<1,2;Cleavage;R1>
<2,H;Oxidation;R1>

>  <CYP2B6>  (64) 


>  <CYP2C8>  (64) 


>  <CYP2C9>  (64) 


>  <CYP2C19>  (64) 
<1,2;Cleavage;R1>
<2,H;Oxidation;R1>
<1,N;N-Oxidation;R2>

>  <CYP2D6>  (64) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <CYP2E1>  (64) 


>  <CYP3A4>  (64) 
<1,2;Cleavage;R1>
<2,H;Oxidation;R1>

>  <References>  (64) 
Jensen KG, Dalgaard L: In vitro metabolism of the M1-muscarinic agonist 5-(2-ethyl-2H-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine by human hepatic cytochromes P-450 determined at pH 7.4 and 8.5. Drug Metab Dispos. 1999 Jan;27(1):125-32. (PMID: 9884321)

>  <Comments>  (64) 
There are some other minor metabolites but they are not recorded here because their metabolic pathway is not identified.

$$$$
CC02547
     RDKit          3D

 17 18  0  0  1  0  0  0  0  0999 V2000
    0.3402   -1.0760    0.1786 O   0  0  0  0  0  0  0  0  0  1  0  0
    0.1740    0.7671    0.0221 N   0  0  0  0  0  0  0  0  0  2  0  0
   -0.1524    0.0964    0.1145 N   0  0  0  0  0  0  0  0  0  3  0  0
    1.6944   -0.4174   -0.0991 N   0  0  0  0  0  0  0  0  0  4  0  0
    0.9005    0.6446   -0.0962 C   0  0  0  0  0  0  0  0  0  5  0  0
    1.0741   -0.0506   -0.0423 C   0  0  0  0  0  0  0  0  0  6  0  0
    0.3843   -0.4265    0.1145 C   0  0  0  0  0  0  0  0  0  7  0  0
   -0.8986   -0.0198    0.0352 C   0  0  0  0  0  0  0  0  0  8  0  0
    1.4048    1.2486   -0.2367 C   0  0  0  0  0  0  0  0  0  9  0  0
   -0.0652    1.3629    0.4684 C   0  0  0  0  0  0  0  0  0 10  0  0
    2.3047   -0.2770    0.3742 C   0  0  0  0  0  0  0  0  0 11  0  0
    1.7564   -1.0633   -0.5411 C   0  0  0  0  0  0  0  0  0 12  0  0
   -1.2081   -0.6592    0.2731 C   0  0  0  0  0  0  0  0  0 13  0  0
   -1.3307    0.5041   -0.2811 C   0  0  0  0  0  0  0  0  0 14  0  0
   -1.9424   -0.7737    0.1953 C   0  0  0  0  0  0  0  0  0 15  0  0
   -2.0651    0.3895   -0.3588 C   0  0  0  0  0  0  0  0  0 16  0  0
   -2.3709   -0.2494   -0.1206 C   0  0  0  0  0  0  0  0  0 17  0  0
  1  7  2  0
  2  3  1  0
  2  5  1  0
  2 10  1  0
  3  7  1  0
  3  8  1  0
  4  6  1  0
  4 11  1  0
  4 12  1  0
  5  6  2  0
  5  9  1  0
  6  7  1  0
  8 13  2  0
  8 14  1  0
 13 15  1  0
 14 16  2  0
 15 17  2  0
 16 17  1  0
M  END
>  <Name>  (65) 
Amidopyrine

>  <InChIKey>  (65) 
RMMXTBMQSGEXHJ-UHFFFAOYSA-N

>  <PubChem_CID>  (65) 
6009

>  <CYP1A2>  (65) 
<15,16;Cleavage;R1>
<16,H;Oxidation;R1>
<15,17;Cleavage;R2>
<17,H;Oxidation;R2>

>  <CYP2A6>  (65) 


>  <CYP2B6>  (65) 


>  <CYP2C8>  (65) 
<15,16;Cleavage;R1>
<16,H;Oxidation;R1>
<15,17;Cleavage;R2>
<17,H;Oxidation;R2>

>  <CYP2C9>  (65) 
<15,16;Cleavage;R1>
<16,H;Oxidation;R1>
<15,17;Cleavage;R2>
<17,H;Oxidation;R2>

>  <CYP2C19>  (65) 
<15,16;Cleavage;R1>
<16,H;Oxidation;R1>
<15,17;Cleavage;R2>
<17,H;Oxidation;R2>

>  <CYP2D6>  (65) 
<15,16;Cleavage;R1>
<16,H;Oxidation;R1>
<15,17;Cleavage;R2>
<17,H;Oxidation;R2>

>  <CYP2E1>  (65) 


>  <CYP3A4>  (65) 
<15,16;Cleavage;R1>
<16,H;Oxidation;R1>
<15,17;Cleavage;R2>
<17,H;Oxidation;R2>

>  <References>  (65) 
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (65) 


$$$$
CC02548
     RDKit          3D

 32 34  0  0  0  0  0  0  0  0999 V2000
    0.1657    1.1150    1.4113 S   0  0  0  0  0  0  0  0  0  1  0  0
   -5.8995   -1.4283    0.5251 F   0  0  0  0  0  0  0  0  0  2  0  0
    3.6195    3.1488   -0.3259 F   0  0  0  0  0  0  0  0  0  3  0  0
    5.4054    2.7851    0.8497 F   0  0  0  0  0  0  0  0  0  4  0  0
    5.4545    2.5188   -1.3079 F   0  0  0  0  0  0  0  0  0  5  0  0
    1.3282   -3.2530   -0.8529 O   0  0  0  0  0  0  0  0  0  6  0  0
   -7.2932    0.5451   -0.4942 O   0  0  0  0  0  0  0  0  0  7  0  0
   -1.1211   -1.0095    0.1636 N   0  0  0  0  0  0  0  0  0  8  0  0
    1.1445   -1.1134    0.0966 N   0  0  0  0  0  0  0  0  0  9  0  0
   -6.4271    2.6213    0.0680 N   0  0  0  0  0  0  0  0  0 10  0  0
    7.7793    0.4166    0.0864 N   0  0  0  0  0  0  0  0  0 11  0  0
   -0.8343   -2.4126   -0.1432 C   0  0  1  0  0  0  0  0  0 12  0  0
    0.6786   -2.3323   -0.3672 C   0  0  0  0  0  0  0  0  0 13  0  0
   -1.0280   -3.3515    1.0563 C   0  0  0  0  0  0  0  0  0 14  0  0
   -1.4871   -2.9445   -1.4218 C   0  0  0  0  0  0  0  0  0 15  0  0
    0.0764   -0.3061    0.5093 C   0  0  0  0  0  0  0  0  0 16  0  0
   -2.4336   -0.4389    0.0707 C   0  0  0  0  0  0  0  0  0 17  0  0
    2.5338   -0.7823    0.0933 C   0  0  0  0  0  0  0  0  0 18  0  0
   -3.5521   -1.2222    0.3468 C   0  0  0  0  0  0  0  0  0 19  0  0
   -2.5854    0.8970   -0.2947 C   0  0  0  0  0  0  0  0  0 20  0  0
    2.9347    0.5465   -0.0476 C   0  0  0  0  0  0  0  0  0 21  0  0
    3.4906   -1.7880    0.2314 C   0  0  0  0  0  0  0  0  0 22  0  0
   -4.8287   -0.6672    0.2571 C   0  0  0  0  0  0  0  0  0 23  0  0
   -3.8620    1.4519   -0.3847 C   0  0  0  0  0  0  0  0  0 24  0  0
    4.2917    0.8694   -0.0506 C   0  0  0  0  0  0  0  0  0 25  0  0
   -4.9835    0.6700   -0.1087 C   0  0  0  0  0  0  0  0  0 26  0  0
    4.8476   -1.4651    0.2286 C   0  0  0  0  0  0  0  0  0 27  0  0
    5.2482   -0.1364    0.0874 C   0  0  0  0  0  0  0  0  0 28  0  0
    4.6841    2.3041   -0.2038 C   0  0  2  0  0  0  0  0  0 29  0  0
   -6.3128    1.2531   -0.2036 C   0  0  0  0  0  0  0  0  0 30  0  0
    6.6466    0.1690    0.0869 C   0  0  0  0  0  0  0  0  0 31  0  0
   -7.6809    3.3396    0.0382 C   0  0  0  0  0  0  0  0  0 32  0  0
  1 16  2  0
  2 23  1  0
 29  3  1  6
  4 29  1  0
  5 29  1  0
  6 13  2  0
  7 30  2  0
  8 12  1  0
  8 16  1  0
  8 17  1  0
  9 13  1  0
  9 16  1  0
  9 18  1  0
 10 30  1  0
 10 32  1  0
 11 31  3  0
 12 13  1  0
 12 14  1  1
 12 15  1  0
 17 19  2  0
 17 20  1  0
 18 21  2  0
 18 22  1  0
 19 23  1  0
 20 24  2  0
 21 25  1  0
 22 27  2  0
 23 26  2  0
 24 26  1  0
 25 28  2  0
 25 29  1  0
 26 30  1  0
 27 28  1  0
 28 31  1  0
M  END
>  <Name>  (66) 
Enzalutamide

>  <InChIKey>  (66) 
WXCXUHSOUPDCQV-UHFFFAOYSA-N

>  <PubChem_CID>  (66) 
15951529

>  <CYP1A2>  (66) 


>  <CYP2A6>  (66) 


>  <CYP2B6>  (66) 


>  <CYP2C8>  (66) 
<11,12;Cleavage;R1>
<12,H;Oxidation;R1>

>  <CYP2C9>  (66) 


>  <CYP2C19>  (66) 


>  <CYP2D6>  (66) 


>  <CYP2E1>  (66) 


>  <CYP3A4>  (66) 
<11,12;Cleavage;R1>
<12,H;Oxidation;R1>

>  <References>  (66) 
Benoist GE, Hendriks RJ, Mulders PF, Gerritsen WR, Somford DM, Schalken JA, van Oort IM, Burger DM, van Erp NP: Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide. Clin Pharmacokinet. 2016 Nov;55(11):1369-1380. doi: 10.1007/s40262-016-0403-6. (PMID: 27106175)

>  <Comments>  (66) 


$$$$
CC02549
     RDKit          3D

 31 32  0  0  0  0  0  0  0  0999 V2000
   -0.6216    3.7318    0.3902 S   0  0  0  0  0  0  0  0  0  1  0  0
    3.7392    2.9444   -0.4866 O   0  0  0  0  0  0  0  0  0  2  0  0
   -6.6291   -0.5340   -1.8353 O   0  0  0  0  0  0  0  0  0  3  0  0
   -7.5381   -1.3705    0.6547 O   0  0  0  0  0  0  0  0  0  4  0  0
   -3.1734   -0.7776    2.4554 O   0  0  0  0  0  0  0  0  0  5  0  0
   -1.3800   -0.7968   -0.3707 O   0  0  0  0  0  0  0  0  0  6  0  0
    6.4031   -0.7592   -0.1855 N   0  0  0  0  0  0  0  0  0  7  0  0
    3.0692    0.7646   -0.8319 N   0  0  0  0  0  0  0  0  0  8  0  0
    0.4928    1.4878   -0.2462 N   0  0  0  0  0  0  0  0  0  9  0  0
   -1.8820    1.4449    0.1569 N   0  0  0  0  0  0  0  0  0 10  0  0
    6.2809   -1.8920   -1.1023 C   0  0  2  0  0  0  0  0  0 11  0  0
    7.1040   -1.1616    1.0335 C   0  0  1  0  0  0  0  0  0 12  0  0
    5.0832   -0.2192    0.1385 C   0  0  0  0  0  0  0  0  0 13  0  0
    4.3811    0.2553   -1.1252 C   0  0  0  0  0  0  0  0  0 14  0  0
    5.4457   -2.9997   -0.4664 C   0  0  0  0  0  0  0  0  0 15  0  0
    7.6715   -2.3980   -1.4724 C   0  0  0  0  0  0  0  0  0 16  0  0
    7.3273    0.0611    1.9178 C   0  0  0  0  0  0  0  0  0 17  0  0
    6.3081   -2.2341    1.7719 C   0  0  0  0  0  0  0  0  0 18  0  0
    2.8398    2.1054   -0.5265 C   0  0  0  0  0  0  0  0  0 19  0  0
    1.4478    2.4619   -0.2183 C   0  0  0  0  0  0  0  0  0 20  0  0
    1.0683    3.7296    0.0981 C   0  0  0  0  0  0  0  0  0 21  0  0
   -0.6558    2.0477    0.0629 C   0  0  0  0  0  0  0  0  0 22  0  0
   -3.5911   -0.3015    0.1423 C   0  0  0  0  0  0  0  0  0 23  0  0
   -2.1701    0.0876   -0.0599 C   0  0  0  0  0  0  0  0  0 24  0  0
   -4.4422   -0.2347   -0.9420 C   0  0  0  0  0  0  0  0  0 25  0  0
   -4.0179   -0.7134    1.3877 C   0  0  0  0  0  0  0  0  0 26  0  0
   -5.7788   -0.5956   -0.7728 C   0  0  0  0  0  0  0  0  0 27  0  0
   -6.2351   -1.0154    0.4768 C   0  0  0  0  0  0  0  0  0 28  0  0
   -5.3547   -1.0744    1.5569 C   0  0  0  0  0  0  0  0  0 29  0  0
   -6.7473   -1.7058   -2.6398 C   0  0  0  0  0  0  0  0  0 30  0  0
   -8.4448   -0.3385    1.0381 C   0  0  0  0  0  0  0  0  0 31  0  0
  1 21  1  0
  1 22  1  0
  2 19  2  0
  3 27  1  0
  3 30  1  0
  4 28  1  0
  4 31  1  0
  5 26  1  0
  6 24  2  0
  7 11  1  0
  7 12  1  0
  7 13  1  0
  8 14  1  0
  8 19  1  0
  9 20  1  0
  9 22  2  0
 10 22  1  0
 10 24  1  0
 11 15  1  1
 11 16  1  0
 12 17  1  1
 12 18  1  0
 13 14  1  0
 19 20  1  0
 20 21  2  0
 23 24  1  0
 23 25  2  0
 23 26  1  0
 25 27  1  0
 26 29  2  0
 27 28  2  0
 28 29  1  0
M  END
>  <Name>  (67) 
Acotiamide

>  <InChIKey>  (67) 
TWHZNAUBXFZMCA-UHFFFAOYSA-N

>  <PubChem_CID>  (67) 
5282338

>  <CYP1A2>  (67) 


>  <CYP2A6>  (67) 


>  <CYP2B6>  (67) 


>  <CYP2C8>  (67) 
<27,28;Cleavage;R1>
<28,H;Oxidation;R1>
<24,25;Cleavage;R2>
<25,H;Oxidation;R2>

>  <CYP2C9>  (67) 


>  <CYP2C19>  (67) 


>  <CYP2D6>  (67) 


>  <CYP2E1>  (67) 


>  <CYP3A4>  (67) 
<27,28;Cleavage;R1>
<28,H;Oxidation;R1>
<24,25;Cleavage;R2>
<25,H;Oxidation;R2>

>  <References>  (67) 
Backman JT, Filppula AM, Niemi M, Neuvonen PJ: Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions. Pharmacol Rev. 2016 Jan;68(1):168-241. doi: 10.1124/pr.115.011411. (PMID: 26721703)
PMDA (2014) Review Report: Acofide [http://www.pmda.go.jp/files/000153467.pdf]

>  <Comments>  (67) 


$$$$
CC02550
     RDKit          3D

 10  9  0  0  1  0  0  0  0  0999 V2000
    0.6123    2.2006   -0.2347 Cl  0  0  0  0  0  0  0  0  0  1  0  0
    2.5543   -0.0301   -0.7397 F   0  0  0  0  0  0  0  0  0  2  0  0
    1.2635   -1.6627   -0.1010 F   0  0  0  0  0  0  0  0  0  3  0  0
    1.8332   -0.1099    1.3213 F   0  0  0  0  0  0  0  0  0  4  0  0
   -3.0010   -0.1659    0.8122 F   0  0  0  0  0  0  0  0  0  5  0  0
   -2.1455   -0.6718   -1.1259 F   0  0  0  0  0  0  0  0  0  6  0  0
   -0.7999    0.1055    0.5067 O   0  0  0  0  0  0  0  0  0  7  0  0
    0.2675    0.4569   -0.3716 C   0  0  2  0  0  0  0  0  0  8  0  0
    1.4906   -0.3365    0.0352 C   0  0  1  0  0  0  0  0  0  9  0  0
   -2.0750    0.2138   -0.1025 C   0  0  2  0  0  0  0  0  0 10  0  0
  8  1  1  1
  9  2  1  6
  3  9  1  0
  4  9  1  0
 10  5  1  1
  6 10  1  0
  7  8  1  0
  7 10  1  0
  8  9  1  0
M  END
>  <Name>  (68) 
Isoflurane

>  <InChIKey>  (68) 
PIWKPBJCKXDKJR-PVQJCKRUSA-N

>  <PubChem_CID>  (68) 
4369440

>  <CYP1A2>  (68) 


>  <CYP2A6>  (68) 


>  <CYP2B6>  (68) 


>  <CYP2C8>  (68) 


>  <CYP2C9>  (68) 


>  <CYP2C19>  (68) 


>  <CYP2D6>  (68) 


>  <CYP2E1>  (68) 
<1,2;Cleavage;R1>
<2,H;Oxidation;R1>

>  <CYP3A4>  (68) 


>  <References>  (68) 
Karpinski T, Szulc R, Szyfter K: Role of Cytochrome P450 in Metabolism of Inhalation Anaesthetics Nowiny Lekarskie. 2006;75(3):292_98.

>  <Comments>  (68) 


$$$$
CC02551
     RDKit          3D

  4  3  0  0  0  0  0  0  0  0999 V2000
    1.6464   -0.7110    0.1375 Cl  0  0  0  0  0  0  0  0  0  1  0  0
   -1.6463   -0.7111   -0.1375 Cl  0  0  0  0  0  0  0  0  0  2  0  0
    0.6836    0.7111   -0.3310 C   0  0  0  0  0  0  0  0  0  3  0  0
   -0.6837    0.7111    0.3310 C   0  0  0  0  0  0  0  0  0  4  0  0
  1  3  1  0
  2  4  1  0
  3  4  1  0
M  END
>  <Name>  (69) 
1,2-Dichloroethane

>  <InChIKey>  (69) 
WSLDOOZREJYCGB-UHFFFAOYSA-N

>  <PubChem_CID>  (69) 
11

>  <CYP1A2>  (69) 


>  <CYP2A6>  (69) 


>  <CYP2B6>  (69) 


>  <CYP2C8>  (69) 


>  <CYP2C9>  (69) 


>  <CYP2C19>  (69) 


>  <CYP2D6>  (69) 


>  <CYP2E1>  (69) 
<3,4;Cleavage;R1>
<3,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP3A4>  (69) 


>  <References>  (69) 
Guengerich FP, Kim DH, Iwasaki M: Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol. 1991 Mar-Apr;4(2):168-79. (PMID: 1664256)
EU Publications (2016) 1,2-Dichloroethane (Ethylene dichloride): Recommendation from the Scientific Committee on Occupational Exposure Limits [https://publications.europa.eu/s/mkjb]

>  <Comments>  (69) 


$$$$
CC02552
     RDKit          3D

  5  4  0  0  0  0  0  0  0  0999 V2000
   -0.5185    0.0447   -0.0001 C   0  0  0  0  0  0  0  0  0  1  0  0
   -0.6822   -1.4501    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    0.8202    0.6168    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -1.5949    0.8486    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    1.9754   -0.0600    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  3  5  2  0
M  END
>  <Name>  (70) 
Isoprene

>  <InChIKey>  (70) 
RRHGJUQNOFWUDK-UHFFFAOYSA-N

>  <PubChem_CID>  (70) 
6557

>  <CYP1A2>  (70) 


>  <CYP2A6>  (70) 


>  <CYP2B6>  (70) 
<3,4;EpOxidation;R1>
<1,5;EpOxidation;R2>

>  <CYP2C8>  (70) 


>  <CYP2C9>  (70) 


>  <CYP2C19>  (70) 


>  <CYP2D6>  (70) 


>  <CYP2E1>  (70) 
<3,4;EpOxidation;R1>
<1,5;EpOxidation;R2>

>  <CYP3A4>  (70) 


>  <References>  (70) 
Bogaards JJ, Venekamp JC, van Bladeren PJ: The biotransformation of isoprene and the two isoprene monoepoxides by human cytochrome P450 enzymes, compared to mouse and rat liver microsomes. Chem Biol Interact. 1996 Dec 20;102(3):169-82. (PMID: 9021169)

>  <Comments>  (70) 


$$$$
CC02553
     RDKit          3D

  5  4  0  0  0  0  0  0  0  0999 V2000
    0.0008   -0.2762    0.0000 O   0  0  0  0  0  0  0  0  0  1  0  0
    1.1747    0.5222    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -1.1754    0.5226    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    2.3873   -0.3840    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -2.3874   -0.3844    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  3  5  1  0
M  END
>  <Name>  (71) 
Diethyl ether

>  <InChIKey>  (71) 
RTZKZFJDLAIYFH-UHFFFAOYSA-N

>  <PubChem_CID>  (71) 
3283

>  <CYP1A2>  (71) 


>  <CYP2A6>  (71) 


>  <CYP2B6>  (71) 


>  <CYP2C8>  (71) 


>  <CYP2C9>  (71) 


>  <CYP2C19>  (71) 


>  <CYP2D6>  (71) 


>  <CYP2E1>  (71) 
<4,1;Cleavage;R1>
<4,H;Oxidation;R1>
<2,1;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP3A4>  (71) 


>  <References>  (71) 
The MAK Collection for Occupational Health and Safety (2012) Diethyl ether [MAK Value Documentation, 1999] [https://onlinelibrary.wiley.com/doi/full/10.1002/3527600418.mb6029e0013]

>  <Comments>  (71) 


$$$$
